(349667, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008661', 'decreased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349668, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0010071', 'abnormal pruritus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349669, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0010753', 'improved mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349670, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349671, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349672, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008670', 'decreased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349673, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003394', 'increased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349674, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003298', 'choking', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349675, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0010211', 'abnormal acute phase protein level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349676, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0031223', 'increased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349677, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0021016', 'decreased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349678, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0011043', 'abnormal lung elastance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349679, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0013559', 'abnormal exocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349680, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0009058', 'decreased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349681, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0000316', 'cellular necrosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349682, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349683, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0030215', 'facial muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349684, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0005617', 'increased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349685, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0011699', 'abnormal brown adipose tissue thermogenesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349686, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003303', 'peritoneal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349687, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008817', 'hematoma', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349688, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0000740', 'impaired smooth muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349689, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0005087', 'decreased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349690, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349691, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020414', 'abnormal fibroblast physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349692, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0005036', 'diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349693, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0005501', 'abnormal skin physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349694, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349695, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0002254', 'reproductive system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349696, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0005410', 'abnormal fertilization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349697, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349698, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349699, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349700, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001790', 'abnormal immune system physiology', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349701, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349702, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003889', 'enhanced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349703, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0030153', 'dental pulp inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349704, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349705, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0013640', 'increased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349706, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0002338', 'abnormal pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349707, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0012608', 'abnormal complement C5 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349708, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020947', 'decreased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349709, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0014048', 'abnormal Peyers patch physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349710, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349711, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001670', 'abnormal intestinal mineral absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349712, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0011012', 'bronchiectasis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349713, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349714, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008712', 'decreased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349715, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0005027', 'increased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349716, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0005004', 'abnormal lymphocyte anergy', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349717, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020155', 'enhanced humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349718, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0004085', 'abnormal heartbeat', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349719, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349720, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349721, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0031111', 'meningoencephalitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349722, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020934', 'increased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349723, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008687', 'increased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349724, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0005005', 'abnormal self tolerance', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349725, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008711', 'increased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349726, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349727, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0011047', 'increased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349728, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0010552', 'abnormal HV interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349729, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003898', 'abnormal QRS complex', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349730, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0004122', 'abnormal sinus arrhythmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349731, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001669', 'abnormal intestinal glucose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349732, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0010950', 'abnormal lung hysteresivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349733, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003278', 'esophageal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349734, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0010377', 'abnormal gut flora balance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349735, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0005190', 'osteomyelitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349736, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0002128', 'abnormal blood circulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349737, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001850', 'increased susceptibility to otitis media', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349738, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349739, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349740, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0011919', 'abnormal R wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349741, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008651', 'increased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349742, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0004829', 'increased anti-chromatin antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349743, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0013627', 'increased vertebra yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349744, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0013641', 'increased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349745, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0009760', 'abnormal mitotic spindle morphology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349746, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0002420', 'abnormal adaptive immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349747, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0031170', 'abnormal vasculature physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349748, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349749, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349750, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349751, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008685', 'decreased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349752, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0005621', 'abnormal cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349753, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349754, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349755, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0011044', 'increased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349756, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0031092', 'dysgeusia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349757, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0010559', 'heart block', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349758, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349759, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0005042', 'abnormal level of surface class II molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349760, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0011432', 'decreased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349761, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003820', 'increased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349762, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0004751', 'increased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349763, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003659', 'abnormal lymph circulation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349764, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0005580', 'periinsulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349765, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008669', 'increased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349766, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0010954', 'abnormal cellular respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349767, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0002296', 'aspiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349768, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0031090', 'ageusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349769, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349770, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003621', 'dysuria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349771, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0031425', 'enhanced male fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349772, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001963', 'abnormal hearing physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349773, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003470', 'abnormal summary potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349774, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008672', 'increased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349775, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349776, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0030909', 'abnormal melanocyte adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349777, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020935', 'decreased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349778, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001984', 'abnormal olfaction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349779, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008722', 'abnormal chemokine secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349780, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003725', 'increased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349781, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0005615', 'increased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349782, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003880', 'abnormal central pattern generator function', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349783, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020950', 'decreased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349784, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008562', 'increased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349785, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349786, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349787, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008942', 'abnormal induced cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349788, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0013135', 'poor circulation in tail', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349789, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008198', 'abnormal follicular dendritic cell antigen presentation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349790, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349791, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020940', 'increased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349792, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349793, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003762', 'abnormal immune organ physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349794, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0031055', 'bronchitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349795, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020916', 'increased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349796, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0004945', 'abnormal bone resorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349797, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0012566', 'decreased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349798, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349799, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0011013', 'bronchiolectasis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349800, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0009247', 'meteorism', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349801, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0012006', 'abnormal hippocampus physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349802, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349803, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001924', 'infertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349804, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349805, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001861', 'lung inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349806, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008684', 'increased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349807, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0011566', 'abnormal complement protein level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349808, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001542', 'abnormal bone strength', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349809, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003699', 'abnormal female reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349810, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0004558', 'delayed allantois development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349811, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003280', 'urinary incontinence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349812, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349813, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003259', 'nausea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349814, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0002472', 'impaired complement alternative pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349815, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349816, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001921', 'reduced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349817, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349818, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020944', 'decreased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349819, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001876', 'decreased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349820, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349821, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008678', 'increased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349822, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349823, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0012554', 'increased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349824, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0013475', 'delayed reproductive senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349825, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0004031', 'insulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349826, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0013752', 'stridor', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349827, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008744', 'abnormal B cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349828, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0010382', 'abnormal dosage compensation, by inactivation of X chromosome', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349829, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349830, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349831, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0031424', 'enhanced female fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349832, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349833, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0004037', 'increased muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349834, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349835, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003866', 'abnormal defecation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349836, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003122', 'maternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349837, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0002471', 'abnormal complement pathway', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349838, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0013561', 'abnormal endocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349839, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001853', 'heart inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349840, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349841, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0002314', 'abnormal respiratory mechanics', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349842, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008706', 'decreased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349843, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349844, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0010504', 'abnormal RR interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349845, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0005043', 'defective assembly of class II molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349846, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0031105', 'rhonchi', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349847, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008006', 'increased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349848, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0011518', 'abnormal cell chemotaxis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349849, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003547', 'abnormal pulmonary pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349850, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0010538', 'increased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349851, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0004994', 'abnormal brain wave pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349852, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001933', 'abnormal litter size', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349853, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001598', 'abnormal blood viscosity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349854, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0010756', 'decreased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349855, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008004', 'abnormal stomach pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349856, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0004149', 'increased bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349857, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0005000', 'abnormal immune tolerance', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349858, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0005671', 'abnormal response to transplant', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349859, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0004759', 'decreased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349860, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0002896', 'abnormal bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349861, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0031222', 'decreased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349862, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020096', 'high mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349863, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0009878', 'decreased susceptibility to bone fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349864, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0009384', 'cardiac valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349865, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008567', 'decreased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349866, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0012382', 'abnormal blood cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349867, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0004145', 'abnormal muscle electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349868, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001840', 'increased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349869, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349870, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008003', 'achlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349871, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0012553', 'decreased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349872, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0031224', 'abnormal CXCL10 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349873, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0030987', 'spinal cord inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349874, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0005275', 'abnormal skin tensile strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349875, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003079', 'decreased susceptibility to induced joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349876, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0030216', 'tongue muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349877, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001533', 'abnormal skeleton physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349878, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0031246', 'abnormal CCL3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349879, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0031089', 'sneezing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349880, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0004510', 'myositis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349881, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349882, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0002333', 'abnormal lung compliance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349883, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349884, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349885, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0005645', 'abnormal hypothalamus physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349886, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349887, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001945', 'bronchoconstriction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349888, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349889, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349890, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0013136', 'genital discharge', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349891, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008001', 'hypochlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349892, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0004036', 'abnormal muscle relaxation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349893, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008564', 'increased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349894, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349895, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0000751', 'myopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349896, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349897, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0012572', 'increased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349898, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008702', 'increased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349899, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003925', 'abnormal cellular glucose uptake', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349900, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0031125', 'aspiration pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349901, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349902, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0000304', 'abnormal cardiac stroke volume', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349903, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0013557', 'abnormal merocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349904, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0004780', 'abnormal surfactant secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349905, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0012111', 'failure of morula compaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349906, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020953', 'decreased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349907, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0002498', 'abnormal acute inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349908, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0002634', 'abnormal sensorimotor gating', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349909, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0000427', 'abnormal hair cycle', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349910, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0002499', 'chronic inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349911, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003393', 'decreased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349912, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0004212', 'abnormal salty taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349913, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0031086', 'wheezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349914, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020946', 'increased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349915, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0030951', 'abnormal endocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349916, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349917, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0013942', 'enthesitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349918, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008699', 'increased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349919, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008943', 'increased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349920, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0014274', 'decreased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349921, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0004213', 'abnormal umami taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349922, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0002164', 'abnormal gland physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349923, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0004782', 'abnormal surfactant physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349924, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008555', 'abnormal interferon secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349925, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0004142', 'abnormal muscle tone', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349926, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349927, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0005532', 'abnormal vascular resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349928, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0010155', 'abnormal intestine physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349929, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003454', 'erythroderma', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349930, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349931, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001983', 'abnormal olfactory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349932, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003467', 'abnormal single cell response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349933, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349934, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0013289', 'abnormal mitotic cytokinesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349935, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008694', 'decreased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349936, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0031402', 'decreased muscle fatigability', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349937, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0014037', 'stranguria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349938, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0031240', 'abnormal CSF3 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349939, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0005044', 'sepsis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349940, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0002473', 'impaired complement classical pathway', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349941, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349942, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349943, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001872', 'sinus inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349944, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0004010', 'increased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349945, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0002106', 'abnormal muscle physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349946, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0004877', 'abnormal systemic vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349947, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0010381', 'abnormal dosage compensation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349948, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003633', 'abnormal nervous system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349949, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020943', 'increased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349950, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008002', 'hyperchlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349951, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349952, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008673', 'decreased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349953, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0009697', 'abnormal copulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349954, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020002', 'increased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349955, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020154', 'impaired humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349956, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0006002', 'abnormal small intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349957, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008751', 'abnormal interleukin level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349958, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0011431', 'increased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349959, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0005076', 'abnormal cell differentiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349960, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349961, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0011082', 'abnormal gastrointestinal motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349962, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003464', 'abnormal single cell response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349963, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0004796', 'increased anti-histone antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349964, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0004803', 'increased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349965, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349966, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0011194', 'abnormal hair follicle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349967, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0031242', 'increased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349968, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0000351', 'increased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349969, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008693', 'increased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349970, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0002064', 'seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349971, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003157', 'impaired muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349972, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0009792', 'seborrheic dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349973, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349974, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0004072', 'abnormal frontal plane axis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349975, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0002336', 'abnormal pulmonary gas exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349976, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020942', 'abnormal susceptibility to Flaviviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349977, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003674', 'oxidative stress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349978, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349979, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0011809', 'abnormal anoikis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349980, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008737', 'abnormal spleen physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349981, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008260', 'abnormal autophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349982, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0002327', 'abnormal respiratory function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349983, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349984, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020381', 'muscle gating pore current', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349985, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0010539', 'decreased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349986, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020371', 'abnormal glymphatic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349987, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0000350', 'abnormal cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349988, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008690', 'increased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349989, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0006114', 'cardiac murmur', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349990, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0012565', 'perivasculitis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349991, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003927', 'increased cellular glucose import', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349992, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349993, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349994, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008752', 'abnormal tumor necrosis factor level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349995, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003767', 'palate inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349996, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020920', 'decreased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349997, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0005616', 'decreased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349998, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0011399', 'increased endoneurial fluid pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349999, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003897', 'abnormal ST segment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350000, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0005613', 'increased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350001, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008664', 'decreased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350002, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350003, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008700', 'decreased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350004, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350005, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008565', 'decreased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350006, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350007, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350008, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0030924', 'early exit from telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350009, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350010, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001800', 'abnormal humoral immune response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350011, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003123', 'paternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350012, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0030129', 'tongue inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350013, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0011763', 'urethritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350014, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350015, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0014275', 'increased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350016, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001866', 'nasal inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350017, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0000343', 'abnormal response to cardiac infarction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350018, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0010695', 'abnormal blood pressure regulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350019, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001950', 'abnormal respiratory sounds', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350020, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350021, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350022, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350023, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003477', 'abnormal nerve fiber response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350024, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0010741', 'abnormal melanocyte proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350025, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350026, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008747', 'abnormal T cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350027, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020845', 'abnormal DNA-templated transcription', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350028, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020919', 'increased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350029, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0005001', 'abnormal clonal deletion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350030, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0011720', 'abnormal ossification involved in bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350031, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0013638', 'decreased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350032, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003463', 'abnormal single cell response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350033, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0011718', 'decreased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350034, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350035, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003412', 'abnormal afterhyperpolarization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350036, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0005614', 'decreased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350037, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020917', 'decreased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350038, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0031104', 'crackles', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350039, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0005025', 'abnormal response to infection', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350040, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350041, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350042, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003077', 'abnormal cell cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350043, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350044, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003882', 'abnormal pulse pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350045, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001761', 'abnormal urination pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350046, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008688', 'decreased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350047, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0010143', 'enhanced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350048, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008679', 'decreased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350049, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001873', 'stomach inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350050, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350051, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0031014', 'polyspermy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350052, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0005597', 'decreased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350053, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003698', 'abnormal male reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350054, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001756', 'abnormal urination', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350055, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350056, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350057, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020039', 'increased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350058, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350059, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0005596', 'increased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350060, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001627', 'abnormal cardiac output', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350061, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003292', 'melena', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350062, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0002933', 'joint inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350063, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350064, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350065, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0009057', 'increased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350066, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0013636', 'abnormal bone stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350067, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350068, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008709', 'decreased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350069, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0002405', 'respiratory system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350070, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0031221', 'abnormal CXCL10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350071, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0013632', 'increased femur maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350072, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001839', 'abnormal level of surface class I molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350073, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350074, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008666', 'increased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350075, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001914', 'hemorrhage', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350076, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350077, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0000738', 'impaired muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350078, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0009045', 'muscle tetany', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350079, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008814', 'decreased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350080, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350081, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350082, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020913', 'increased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350083, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001864', 'vascular inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350084, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350085, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008696', 'increased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350086, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0011918', 'abnormal PQ interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350087, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0013296', 'abnormal susceptibility to induced colitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350088, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0031088', 'coughing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350089, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003878', 'abnormal ear physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350090, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008658', 'decreased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350091, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0005612', 'decreased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350092, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0031054', 'bronchiolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350093, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0013498', 'trachea inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350094, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350095, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350096, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0002330', 'abnormal bronchial provocation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350097, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0010752', 'impaired mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350098, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0005402', 'abnormal action potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350099, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020952', 'increased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350100, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0002993', 'arthritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350101, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350102, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350103, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0010994', 'aerophagia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350104, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350105, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350106, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350107, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0006082', 'CNS inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350108, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0011927', 'abnormal cardiac valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350109, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0004011', 'decreased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350110, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001648', 'abnormal apoptosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350111, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0011046', 'abnormal lung tissue damping', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350112, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001867', 'rhinitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350113, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0000743', 'muscle spasm', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350114, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0005666', 'abnormal adipose tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350115, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008682', 'decreased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350116, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0004143', 'muscle hypertonia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350117, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350118, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008667', 'decreased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350119, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0011951', 'increased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350120, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001634', 'internal hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350121, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0013634', 'increased femur fracture load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350122, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0010822', 'pneumothorax', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350123, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0031095', 'pharyngitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350124, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003116', 'rickets', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350125, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0012573', 'decreased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350126, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0009046', 'muscle twitch', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350127, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350128, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0000423', 'delayed hair regrowth', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350129, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0002133', 'abnormal respiratory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350130, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350131, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0010758', 'increased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350132, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0012120', 'trophectoderm cell degeneration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350133, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003701', 'elevated level of mitotic sister chromatid exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350134, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0002322', 'abnormal respiratory transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350135, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0013642', 'decreased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350136, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001636', 'irregular heartbeat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350137, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350138, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350139, 'HP:0011428', 'Short fetal femur length', 'MP:0030222', 'hyperostosis', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(350140, 'HP:0011428', 'Short fetal femur length', 'MP:0012070', 'abnormal susceptibility to osteoporosis', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(350141, 'HP:0011428', 'Short fetal femur length', 'MP:0005422', 'osteosclerosis', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(350142, 'HP:0011428', 'Short fetal femur length', 'MP:0010874', 'abnormal bone volume', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(350143, 'HP:0011428', 'Short fetal femur length', 'MP:0005508', 'abnormal skeleton morphology', 0.4444444444444444, 4.825104621810128, 1.4644080520902374, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(350144, 'HP:0011428', 'Short fetal femur length', 'MP:0002114', 'abnormal axial skeleton morphology', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(350145, 'HP:0011428', 'Short fetal femur length', 'MP:0002113', 'abnormal skeleton development', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(350146, 'HP:0011428', 'Short fetal femur length', 'MP:0000566', 'synostosis', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(350147, 'HP:0011428', 'Short fetal femur length', 'MP:0003795', 'abnormal bone structure', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(350148, 'HP:0011428', 'Short fetal femur length', 'MP:0030485', 'abnormal osteocyte lacunocanalicular system morphology', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(350149, 'HP:0011428', 'Short fetal femur length', 'MP:0009250', 'abnormal appendicular skeleton morphology', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(350150, 'HP:0011428', 'Short fetal femur length', 'MP:0013304', 'osteophytes', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(350151, 'HP:0011428', 'Short fetal femur length', 'MP:0005504', 'abnormal ligament morphology', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(350152, 'HP:0011428', 'Short fetal femur length', 'MP:0010122', 'abnormal bone mineral content', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(350153, 'HP:0011428', 'Short fetal femur length', 'MP:0002932', 'abnormal joint morphology', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(350154, 'HP:0011428', 'Short fetal femur length', 'MP:0009877', 'exostosis', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(350155, 'HP:0011428', 'Short fetal femur length', 'MP:0031348', 'bone fibrous dysplasia', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(350156, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350157, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0011718', 'decreased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350158, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0030990', 'nerve inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350159, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0010950', 'abnormal lung hysteresivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350160, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0011012', 'bronchiectasis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350161, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0010758', 'increased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350162, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350163, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0005612', 'decreased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350164, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0010211', 'abnormal acute phase protein level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350165, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0005402', 'abnormal action potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350166, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003865', 'lymph node inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350167, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0002164', 'abnormal gland physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350168, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0000316', 'cellular necrosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350169, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020935', 'decreased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350170, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003925', 'abnormal cellular glucose uptake', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350171, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0013638', 'decreased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350172, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0000751', 'myopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350173, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0002473', 'impaired complement classical pathway', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350174, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003674', 'oxidative stress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350175, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0013134', 'poor circulation in autopods', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350176, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0031469', 'abnormal pinocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350177, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350178, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350179, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008702', 'increased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350180, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008705', 'increased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350181, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001664', 'abnormal digestion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350182, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0004212', 'abnormal salty taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350183, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008817', 'hematoma', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350184, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001819', 'abnormal immune cell physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350185, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003116', 'rickets', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350186, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003278', 'esophageal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350187, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008002', 'hyperchlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350188, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008666', 'increased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350189, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008861', 'abnormal hair shedding', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350190, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020000', 'abnormal response to antigen', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350191, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0002993', 'arthritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350192, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001846', 'increased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350193, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350194, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0012566', 'decreased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350195, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350196, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350197, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0002723', 'abnormal immune serum protein physiology', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350198, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350199, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003898', 'abnormal QRS complex', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350200, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350201, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008943', 'increased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350202, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003621', 'dysuria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350203, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350204, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0004046', 'abnormal mitosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350205, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350206, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0002841', 'impaired skeletal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350207, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350208, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001849', 'ear inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350209, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350210, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0005620', 'abnormal muscle contractility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350211, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008700', 'decreased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350212, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0010377', 'abnormal gut flora balance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350213, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350214, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001933', 'abnormal litter size', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350215, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003820', 'increased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350216, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0031092', 'dysgeusia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350217, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0031104', 'crackles', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350218, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0004011', 'decreased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350219, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0011809', 'abnormal anoikis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350220, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0002322', 'abnormal respiratory transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350221, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0000313', 'abnormal cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350222, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0011925', 'abnormal heart echocardiography feature', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350223, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0002336', 'abnormal pulmonary gas exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350224, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001841', 'decreased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350225, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0004143', 'muscle hypertonia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350226, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0010155', 'abnormal intestine physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350227, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003880', 'abnormal central pattern generator function', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350228, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003726', 'decreased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350229, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350230, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001542', 'abnormal bone strength', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350231, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003868', 'abnormal feces composition', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350232, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008667', 'decreased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350233, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001835', 'abnormal antigen presentation', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350234, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0005088', 'increased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350235, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020942', 'abnormal susceptibility to Flaviviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350236, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0013637', 'increased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350237, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003186', 'abnormal redox activity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350238, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350239, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0005613', 'increased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350240, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350241, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0004945', 'abnormal bone resorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350242, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0010741', 'abnormal melanocyte proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350243, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008664', 'decreased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350244, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350245, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001876', 'decreased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350246, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350247, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350248, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0011919', 'abnormal R wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350249, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350250, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0011046', 'abnormal lung tissue damping', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350251, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008271', 'abnormal bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350252, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350253, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008651', 'increased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350254, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001947', 'abnormal mucociliary clearance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350255, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0005087', 'decreased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350256, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350257, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350258, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0031128', 'cardiovascular shunt', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350259, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001862', 'interstitial pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350260, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0006003', 'abnormal large intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350261, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0000738', 'impaired muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350262, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0009062', 'impaired lectin complement pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350263, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0031424', 'enhanced female fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350264, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020097', 'low mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350265, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0010753', 'improved mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350266, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008748', 'abnormal central T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350267, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0006002', 'abnormal small intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350268, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003824', 'decreased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350269, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0006082', 'CNS inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350270, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0004512', 'anosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350271, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020039', 'increased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350272, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350273, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003412', 'abnormal afterhyperpolarization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350274, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0030987', 'spinal cord inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350275, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003659', 'abnormal lymph circulation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350276, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008944', 'decreased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350277, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020154', 'impaired humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350278, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001845', 'abnormal inflammatory response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350279, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003077', 'abnormal cell cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350280, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0002635', 'reduced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350281, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350282, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350283, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350284, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008660', 'increased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350285, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020386', 'adipose tissue inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350286, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0000343', 'abnormal response to cardiac infarction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350287, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003633', 'abnormal nervous system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350288, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0004149', 'increased bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350289, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008567', 'decreased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350290, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0004761', 'increased susceptibility to induced pancreatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350291, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0013634', 'increased femur fracture load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350292, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0000740', 'impaired smooth muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350293, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350294, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0012565', 'perivasculitis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350295, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0031169', 'abnormal joint physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350296, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008564', 'increased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350297, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0031095', 'pharyngitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350298, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0013625', 'increased femur yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350299, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0010505', 'abnormal T wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350300, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350301, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0002419', 'abnormal innate immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350302, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020916', 'increased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350303, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350304, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350305, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350306, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0004829', 'increased anti-chromatin antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350307, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350308, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0013475', 'delayed reproductive senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350309, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008563', 'decreased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350310, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350311, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008669', 'increased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350312, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001636', 'irregular heartbeat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350313, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350314, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003091', 'abnormal cell migration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350315, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008721', 'abnormal chemokine level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350316, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350317, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0005333', 'decreased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350318, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0005363', 'decreased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350319, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0013641', 'increased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350320, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020917', 'decreased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350321, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0013498', 'trachea inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350322, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0013557', 'abnormal merocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350323, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020922', 'increased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350324, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0012111', 'failure of morula compaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350325, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0031129', 'left-to-right shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350326, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008558', 'abnormal interferon-beta secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350327, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008555', 'abnormal interferon secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350328, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350329, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350330, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020938', 'decreased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350331, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350332, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0005000', 'abnormal immune tolerance', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350333, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0013642', 'decreased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350334, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350335, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0010552', 'abnormal HV interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350336, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350337, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350338, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0030130', 'gum inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350339, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0030216', 'tongue muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350340, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350341, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350342, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0009046', 'muscle twitch', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350343, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020947', 'decreased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350344, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0005410', 'abnormal fertilization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350345, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0012382', 'abnormal blood cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350346, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008693', 'increased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350347, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001853', 'heart inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350348, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0004751', 'increased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350349, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001194', 'dermatitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350350, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0013636', 'abnormal bone stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350351, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008678', 'increased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350352, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0012608', 'abnormal complement C5 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350353, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001669', 'abnormal intestinal glucose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350354, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350355, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0002498', 'abnormal acute inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350356, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003699', 'abnormal female reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350357, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0012197', 'impaired myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350358, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008751', 'abnormal interleukin level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350359, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001790', 'abnormal immune system physiology', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350360, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0010504', 'abnormal RR interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350361, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350362, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0031125', 'aspiration pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350363, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350364, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003878', 'abnormal ear physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350365, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0002409', 'decreased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350366, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0005001', 'abnormal clonal deletion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350367, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003767', 'palate inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350368, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350369, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008713', 'abnormal cytokine level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350370, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001850', 'increased susceptibility to otitis media', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350371, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0000351', 'increased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350372, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020953', 'decreased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350373, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350374, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008814', 'decreased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350375, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350376, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0009058', 'decreased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350377, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350378, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0004877', 'abnormal systemic vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350379, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0004145', 'abnormal muscle electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350380, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001864', 'vascular inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350381, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0031091', 'hypogeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350382, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020940', 'increased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350383, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003897', 'abnormal ST segment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350384, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0012685', 'abnormal primitive streak elongation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350385, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350386, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350387, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0002314', 'abnormal respiratory mechanics', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350388, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003393', 'decreased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350389, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0031222', 'decreased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350390, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350391, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0011013', 'bronchiolectasis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350392, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0013296', 'abnormal susceptibility to induced colitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350393, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008737', 'abnormal spleen physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350394, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0002327', 'abnormal respiratory function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350395, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001851', 'eye inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350396, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350397, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020925', 'increased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350398, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0010539', 'decreased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350399, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0011431', 'increased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350400, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0010073', 'decreased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350401, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0010954', 'abnormal cellular respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350402, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0030132', 'periodontium inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350403, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003260', 'vomiting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350404, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0004211', 'abnormal sour taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350405, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350406, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350407, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350408, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0013971', 'blood in lymph vessels', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350409, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350410, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001761', 'abnormal urination pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350411, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003470', 'abnormal summary potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350412, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008775', 'abnormal heart ventricle pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350413, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020845', 'abnormal DNA-templated transcription', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350414, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350415, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020002', 'increased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350416, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008673', 'decreased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350417, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003292', 'melena', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350418, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001985', 'abnormal gustatory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350419, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008663', 'increased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350420, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350421, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350422, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350423, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001963', 'abnormal hearing physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350424, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008691', 'decreased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350425, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0004142', 'abnormal muscle tone', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350426, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350427, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0031240', 'abnormal CSF3 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350428, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001984', 'abnormal olfaction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350429, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008260', 'abnormal autophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350430, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350431, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008722', 'abnormal chemokine secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350432, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0005616', 'decreased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350433, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0011047', 'increased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350434, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350435, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0002998', 'abnormal bone remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350436, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0013632', 'increased femur maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350437, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020371', 'abnormal glymphatic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350438, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350439, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350440, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0005596', 'increased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350441, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0000503', 'excessive digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350442, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0009643', 'abnormal urine homeostasis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350443, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0004558', 'delayed allantois development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350444, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350445, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350446, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350447, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001858', 'intestinal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350448, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0031086', 'wheezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350449, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350450, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350451, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0011566', 'abnormal complement protein level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350452, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0002634', 'abnormal sensorimotor gating', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350453, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350454, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350455, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0010381', 'abnormal dosage compensation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350456, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0013136', 'genital discharge', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350457, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020142', 'increased anti-sperm antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350458, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0031098', 'abnormal sputum production', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350459, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003298', 'choking', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350460, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0005666', 'abnormal adipose tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350461, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020040', 'decreased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350462, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0011804', 'increased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350463, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0010368', 'abnormal lymphatic system physiology', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350464, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0012556', 'increased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350465, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001914', 'hemorrhage', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350466, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350467, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350468, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350469, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0002693', 'abnormal pancreas physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350470, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003547', 'abnormal pulmonary pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350471, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0002333', 'abnormal lung compliance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350472, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350473, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350474, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350475, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0002578', 'impaired ability to fire action potentials', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350476, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350477, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0011918', 'abnormal PQ interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350478, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020950', 'decreased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350479, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350480, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001986', 'abnormal taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350481, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350482, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008001', 'hypochlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350483, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350484, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350485, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003823', 'increased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350486, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0002471', 'abnormal complement pathway', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350487, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350488, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0011805', 'decreased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350489, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0002410', 'decreased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350490, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008675', 'increased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350491, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350492, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008661', 'decreased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350493, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350494, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0011432', 'decreased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350495, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350496, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0005645', 'abnormal hypothalamus physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350497, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0010382', 'abnormal dosage compensation, by inactivation of X chromosome', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350498, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0013644', 'increased vertebra maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350499, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003471', 'abnormal summary potential threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350500, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0004947', 'skin inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350501, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003259', 'nausea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350502, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020931', 'increased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350503, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008006', 'increased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350504, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350505, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350506, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350507, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350508, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0004009', 'abnormal diastolic filling velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350509, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0009567', 'mitotic nondisjunction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350510, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350511, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0005253', 'abnormal eye physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350512, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350513, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0002405', 'respiratory system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350514, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350515, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001666', 'abnormal intestinal absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350516, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0011763', 'urethritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350517, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0031066', 'cytokine storm', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350518, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0010143', 'enhanced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350519, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008681', 'increased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350520, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350521, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350522, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350523, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350524, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003777', 'lip inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350525, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0005044', 'sepsis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350526, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350527, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0005190', 'osteomyelitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350528, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0009384', 'cardiac valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350529, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350530, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0002297', 'abnormal forced expiratory flow rates', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350531, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0010680', 'abnormal skin adnexa physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350532, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0011920', 'abnormal S wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350533, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0011399', 'increased endoneurial fluid pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350534, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0009562', 'abnormal odor adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350535, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0002064', 'seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350536, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0004072', 'abnormal frontal plane axis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350537, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003463', 'abnormal single cell response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350538, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0010752', 'impaired mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350539, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0031402', 'decreased muscle fatigability', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350540, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003477', 'abnormal nerve fiber response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350541, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0004037', 'increased muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350542, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0010695', 'abnormal blood pressure regulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350543, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020412', 'abnormal amnion physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350544, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008942', 'abnormal induced cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350545, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001668', 'abnormal intestinal fructose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350546, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0009057', 'increased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350547, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0031246', 'abnormal CCL3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350548, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0011044', 'increased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350549, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001921', 'reduced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350550, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350551, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0005615', 'increased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350552, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0000427', 'abnormal hair cycle', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350553, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0002106', 'abnormal muscle physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350554, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0031051', 'lymph node hemorrhage', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350555, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0000743', 'muscle spasm', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350556, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001598', 'abnormal blood viscosity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350557, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001837', 'defective assembly of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350558, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0012006', 'abnormal hippocampus physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350559, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350560, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0031223', 'increased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350561, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008708', 'increased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350562, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0013752', 'stridor', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350563, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0013459', 'perioral dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350564, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0031090', 'ageusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350565, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0030153', 'dental pulp inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350566, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0031088', 'coughing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350567, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003464', 'abnormal single cell response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350568, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003157', 'impaired muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350569, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020944', 'decreased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350570, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008703', 'decreased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350571, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0000505', 'decreased digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350572, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008684', 'increased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350573, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020096', 'high mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350574, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350575, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0005671', 'abnormal response to transplant', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350576, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0005621', 'abnormal cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350577, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0009760', 'abnormal mitotic spindle morphology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350578, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0009473', 'abnormal skin exfoliation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350579, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350580, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0005027', 'increased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350581, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003762', 'abnormal immune organ physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350582, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020937', 'increased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350583, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001533', 'abnormal skeleton physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350584, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350585, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0030129', 'tongue inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350586, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008672', 'increased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350587, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0021021', 'abnormal adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350588, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020155', 'enhanced humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350589, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0013640', 'increased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350590, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0031425', 'enhanced male fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350591, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003079', 'decreased susceptibility to induced joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350592, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0000304', 'abnormal cardiac stroke volume', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350593, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008694', 'decreased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350594, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001945', 'bronchoconstriction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350595, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008562', 'increased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350596, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350597, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0012572', 'increased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350598, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0002128', 'abnormal blood circulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350599, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350600, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020952', 'increased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350601, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001872', 'sinus inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350602, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350603, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008706', 'decreased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350604, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350605, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003474', 'abnormal summary potential intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350606, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350607, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0030988', 'dysosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350608, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350609, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0011082', 'abnormal gastrointestinal motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350610, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008747', 'abnormal T cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350611, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0009878', 'decreased susceptibility to bone fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350612, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0011518', 'abnormal cell chemotaxis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350613, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0004122', 'abnormal sinus arrhythmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350614, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003787', 'abnormal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350615, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0004010', 'increased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350616, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0005275', 'abnormal skin tensile strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350617, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020846', 'abnormal cell motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350618, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008699', 'increased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350619, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0031013', 'abnormal egg activation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350620, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008750', 'abnormal interferon level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350621, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020941', 'decreased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350622, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0002933', 'joint inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350623, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0031241', 'decreased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350624, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008004', 'abnormal stomach pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350625, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0005580', 'periinsulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350626, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0005043', 'defective assembly of class II molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350627, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350628, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0005597', 'decreased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350629, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001839', 'abnormal level of surface class I molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350630, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0031053', 'pleuritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350631, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003725', 'increased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350632, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001627', 'abnormal cardiac output', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350633, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350634, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001634', 'internal hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350635, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0010756', 'decreased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350636, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0011194', 'abnormal hair follicle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350637, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001663', 'abnormal digestive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350638, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350639, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350640, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350641, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350642, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350643, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0010922', 'alveolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350644, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003698', 'abnormal male reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350645, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0013135', 'poor circulation in tail', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350646, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350647, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008658', 'decreased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350648, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0031102', 'rhinorrhea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350649, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008690', 'increased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350650, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020414', 'abnormal fibroblast physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350651, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0031014', 'polyspermy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350652, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001873', 'stomach inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350653, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0005617', 'increased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350654, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008652', 'decreased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350655, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0004782', 'abnormal surfactant physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350656, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003566', 'abnormal cell adhesion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350657, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001633', 'poor circulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350658, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0004781', 'abnormal surfactant composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350659, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350660, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008711', 'increased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350661, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001866', 'nasal inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350662, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0011936', 'abnormal PP interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350663, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001800', 'abnormal humoral immune response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350664, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0005614', 'decreased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350665, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008744', 'abnormal B cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350666, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350667, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0000423', 'delayed hair regrowth', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350668, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350669, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0002500', 'granulomatous inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350670, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0031111', 'meningoencephalitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350671, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0002338', 'abnormal pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350672, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350673, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0002161', 'abnormal fertility/fecundity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350674, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350675, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0002842', 'increased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350676, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350677, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350678, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0031170', 'abnormal vasculature physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350679, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0006001', 'abnormal intestinal transit time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350680, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350681, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0030215', 'facial muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350682, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0002330', 'abnormal bronchial provocation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350683, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350684, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0031009', 'abnormal sperm-egg fusion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350685, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0004484', 'abnormal response of heart to induced stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350686, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0011926', 'abnormal heart valve physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350687, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0002626', 'increased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350688, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0002296', 'aspiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350689, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0030822', 'sacroiliac joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350690, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003866', 'abnormal defecation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350691, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020943', 'increased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350692, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0005025', 'abnormal response to infection', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350693, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350694, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0004803', 'increased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350695, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003123', 'paternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350696, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0010538', 'increased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350697, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0030909', 'abnormal melanocyte adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350698, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0004759', 'decreased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350699, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0012553', 'decreased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350700, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0030924', 'early exit from telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350701, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350702, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008685', 'decreased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350703, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0012120', 'trophectoderm cell degeneration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350704, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020001', 'decreased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350705, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008687', 'increased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350706, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0009045', 'muscle tetany', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350707, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350708, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003882', 'abnormal pulse pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350709, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0010560', 'intraventricular block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350710, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008003', 'achlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350711, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0012554', 'increased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350712, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0014274', 'decreased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350713, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350714, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020848', 'abnormal exocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350715, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350716, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0031306', 'abnormal cartilage physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350717, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350718, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350719, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350720, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001943', 'abnormal respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350721, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0004155', 'decreased susceptibility to induced pancreatitis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350722, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020147', 'abnormal defecation amount', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350723, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350724, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0010822', 'pneumothorax', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350725, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0004213', 'abnormal umami taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350726, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020949', 'increased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350727, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350728, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0005004', 'abnormal lymphocyte anergy', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350729, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001924', 'infertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350730, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0013806', 'encephalopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350731, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001756', 'abnormal urination', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350732, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0002472', 'impaired complement alternative pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350733, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0004085', 'abnormal heartbeat', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350734, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0000501', 'abnormal digestive secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350735, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350736, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0013289', 'abnormal mitotic cytokinesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350737, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0031224', 'abnormal CXCL10 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350738, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0014048', 'abnormal Peyers patch physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350739, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350740, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0004760', 'increased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350741, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008676', 'decreased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350742, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003467', 'abnormal single cell response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350743, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008709', 'decreased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350744, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0010072', 'increased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350745, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003454', 'erythroderma', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350746, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0013561', 'abnormal endocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350747, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0014275', 'increased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350748, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350749, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0004031', 'insulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350750, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020381', 'muscle gating pore current', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350751, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350752, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001629', 'abnormal heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350753, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008776', 'increased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350754, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0005364', 'increased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350755, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008682', 'decreased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350756, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001670', 'abnormal intestinal mineral absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350757, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0014026', 'abnormal respiratory epithelial transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350758, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008565', 'decreased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350759, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003261', 'hematemesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350760, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0002418', 'increased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350761, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0011764', 'ureteritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350762, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0031130', 'right-to-left shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350763, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0005501', 'abnormal skin physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350764, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0004780', 'abnormal surfactant secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350765, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0031054', 'bronchiolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350766, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0002421', 'abnormal cell-mediated immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350767, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0006080', 'brain ischemia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350768, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008007', 'abnormal cellular replicative senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350769, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0010071', 'abnormal pruritus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350770, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0004752', 'decreased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350771, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0004796', 'increased anti-histone antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350772, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0002133', 'abnormal respiratory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350773, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0013555', 'abnormal apocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350774, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008712', 'decreased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350775, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003009', 'abnormal cytokine secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350776, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0002406', 'increased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350777, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350778, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0000350', 'abnormal cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350779, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008272', 'abnormal endochondral bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350780, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0011717', 'increased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350781, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0006114', 'cardiac murmur', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350782, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003889', 'enhanced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350783, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0031055', 'bronchitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350784, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0005042', 'abnormal level of surface class II molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350785, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008005', 'decreased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350786, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003899', 'abnormal QT interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350787, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0000352', 'decreased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350788, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0002254', 'reproductive system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350789, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003927', 'increased cellular glucose import', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350790, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0013639', 'decreased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350791, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0006138', 'congestive heart failure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350792, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0011720', 'abnormal ossification involved in bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350793, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003926', 'decreased cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350794, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350795, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001844', 'autoimmune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350796, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350797, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0011762', 'renal/urinary system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350798, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350799, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0005403', 'abnormal nerve conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350800, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0005399', 'increased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350801, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008544', 'impaired olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350802, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008568', 'abnormal interleukin secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350803, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0031302', 'syncope', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350804, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0004994', 'abnormal brain wave pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350805, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0004036', 'abnormal muscle relaxation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350806, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0011951', 'increased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350807, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001950', 'abnormal respiratory sounds', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350808, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0011045', 'decreased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350809, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0012555', 'decreased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350810, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008688', 'decreased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350811, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001648', 'abnormal apoptosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350812, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350813, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001983', 'abnormal olfactory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350814, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020934', 'increased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350815, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0013627', 'increased vertebra yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350816, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350817, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020926', 'decreased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350818, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003280', 'urinary incontinence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350819, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350820, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0009792', 'seborrheic dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350821, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0010994', 'aerophagia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350822, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0011048', 'decreased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350823, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020946', 'increased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350824, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350825, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0005532', 'abnormal vascular resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350826, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0031105', 'rhonchi', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350827, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008566', 'increased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350828, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350829, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003746', 'stomatitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350830, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350831, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0005398', 'decreased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350832, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008752', 'abnormal tumor necrosis factor level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350833, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020920', 'decreased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350834, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0011952', 'decreased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350835, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001793', 'abnormal susceptibility to infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350836, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0014030', 'abnormal mucous gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350837, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350838, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0011043', 'abnormal lung elastance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350839, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0031126', 'gangrene', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350840, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350841, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0014037', 'stranguria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350842, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0031089', 'sneezing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350843, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0009732', 'ventricular premature beat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350844, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0009697', 'abnormal copulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350845, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0011994', 'increased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350846, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0013556', 'abnormal holocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350847, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0031242', 'increased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350848, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350849, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350850, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350851, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350852, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003701', 'elevated level of mitotic sister chromatid exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350853, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003122', 'maternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350854, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001847', 'brain inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350855, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0021015', 'increased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350856, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0030214', 'muscle fasciculation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350857, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003875', 'abnormal hair follicle regression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350858, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008696', 'increased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350859, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0004510', 'myositis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350860, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003394', 'increased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350861, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0005005', 'abnormal self tolerance', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350862, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0010559', 'heart block', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350863, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0013942', 'enthesitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350864, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0009247', 'meteorism', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350865, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008198', 'abnormal follicular dendritic cell antigen presentation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350866, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0003303', 'peritoneal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350867, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008697', 'decreased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350868, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0005036', 'diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350869, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008670', 'decreased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350870, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350871, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020919', 'increased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350872, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0002694', 'abnormal pancreas secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350873, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001861', 'lung inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350874, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350875, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0030951', 'abnormal endocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350876, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0030991', 'optic nerve inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350877, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0011927', 'abnormal cardiac valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350878, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350879, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0002896', 'abnormal bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350880, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0031221', 'abnormal CXCL10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350881, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008679', 'decreased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350882, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0012573', 'decreased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350883, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350884, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001867', 'rhinitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350885, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020138', 'delayed bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350886, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350887, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020913', 'increased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350888, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0031110', 'meningitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350889, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0005076', 'abnormal cell differentiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350890, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0011699', 'abnormal brown adipose tissue thermogenesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350891, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001840', 'increased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350892, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0021016', 'decreased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350893, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350894, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001951', 'abnormal breathing pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350895, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0002420', 'abnormal adaptive immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350896, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350897, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350898, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350899, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0002499', 'chronic inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350900, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001919', 'abnormal reproductive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350901, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0001869', 'pancreas inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350902, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350903, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0013559', 'abnormal exocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350904, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(350905, 'HP:0034106', 'Anti-Su antigen/argonaute 2 antibody positivity', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(350906, 'HP:0100758', 'Gangrene', 'MP:0010768', 'mortality/aging', 0.42857142857142855, 1.5524157786304194, 0.8156721449114622, 'UPHENO:0001003', 'phenotype by ontology source'),
(350907, 'HP:0100758', 'Gangrene', 'MP:0010233', 'hairless tail', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350908, 'HP:0100758', 'Gangrene', 'MP:0005367', 'renal/urinary system phenotype', 0.42857142857142855, 1.5524157786304194, 0.8156721449114622, 'UPHENO:0001003', 'phenotype by ontology source'),
(350909, 'HP:0100758', 'Gangrene', 'MP:0005388', 'respiratory system phenotype', 0.42857142857142855, 1.5524157786304194, 0.8156721449114622, 'UPHENO:0001003', 'phenotype by ontology source'),
(350910, 'HP:0100758', 'Gangrene', 'MP:0005381', 'digestive/alimentary phenotype', 0.42857142857142855, 1.5524157786304194, 0.8156721449114622, 'UPHENO:0001003', 'phenotype by ontology source'),
(350911, 'HP:0100758', 'Gangrene', 'MP:0030627', 'abnormal methylmalonic acid level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350912, 'HP:0100758', 'Gangrene', 'MP:0005397', 'hematopoietic system phenotype', 0.42857142857142855, 1.5524157786304194, 0.8156721449114622, 'UPHENO:0001003', 'phenotype by ontology source'),
(350913, 'HP:0100758', 'Gangrene', 'MP:0010999', 'proteinosis', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350914, 'HP:0100758', 'Gangrene', 'MP:0014134', 'abnormal embryo morphology', 0.4444444444444444, 1.6758249395539064, 0.8630243821852199, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350915, 'HP:0100758', 'Gangrene', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.4444444444444444, 1.6758249395539064, 0.8630243821852199, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350916, 'HP:0100758', 'Gangrene', 'MP:0005371', 'limbs/digits/tail phenotype', 0.42857142857142855, 1.5524157786304194, 0.8156721449114622, 'UPHENO:0001003', 'phenotype by ontology source'),
(350917, 'HP:0100758', 'Gangrene', 'MP:0010771', 'integument phenotype', 0.42857142857142855, 1.5524157786304194, 0.8156721449114622, 'UPHENO:0001003', 'phenotype by ontology source'),
(350918, 'HP:0100758', 'Gangrene', 'MP:0005378', 'growth/size/body region phenotype', 0.42857142857142855, 1.5524157786304194, 0.8156721449114622, 'UPHENO:0001003', 'phenotype by ontology source'),
(350919, 'HP:0100758', 'Gangrene', 'MP:0014137', 'abnormal preimplantation embryo morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350920, 'HP:0100758', 'Gangrene', 'MP:0005500', 'abnormal gustatory system morphology', 0.4444444444444444, 1.6758249395539064, 0.8630243821852199, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350921, 'HP:0100758', 'Gangrene', 'MP:0005385', 'cardiovascular system phenotype', 0.42857142857142855, 1.5524157786304194, 0.8156721449114622, 'UPHENO:0001003', 'phenotype by ontology source'),
(350922, 'HP:0100758', 'Gangrene', 'MP:0012007', 'abnormal chloride level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350923, 'HP:0100758', 'Gangrene', 'MP:0013118', 'swellings', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350924, 'HP:0100758', 'Gangrene', 'MP:0002163', 'abnormal gland morphology', 0.4444444444444444, 1.6758249395539064, 0.8630243821852199, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350925, 'HP:0100758', 'Gangrene', 'MP:0006281', 'abnormal tail development', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350926, 'HP:0100758', 'Gangrene', 'MP:0013215', 'abnormal haptoglobin level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350927, 'HP:0100758', 'Gangrene', 'MP:0005386', 'behavior/neurological phenotype', 0.42857142857142855, 1.5524157786304194, 0.8156721449114622, 'UPHENO:0001003', 'phenotype by ontology source'),
(350928, 'HP:0100758', 'Gangrene', 'MP:0005376', 'homeostasis/metabolism phenotype', 0.42857142857142855, 1.5524157786304194, 0.8156721449114622, 'UPHENO:0001003', 'phenotype by ontology source'),
(350929, 'HP:0100758', 'Gangrene', 'MP:0031310', 'abnormal cyst', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350930, 'HP:0100758', 'Gangrene', 'MP:0005391', 'vision/eye phenotype', 0.42857142857142855, 1.5524157786304194, 0.8156721449114622, 'UPHENO:0001003', 'phenotype by ontology source'),
(350931, 'HP:0100758', 'Gangrene', 'MP:0002160', 'abnormal reproductive system morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350932, 'HP:0100758', 'Gangrene', 'MP:0030754', 'abnormal histamine level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350933, 'HP:0100758', 'Gangrene', 'MP:0031337', 'abnormal lipocalin 2 level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350934, 'HP:0100758', 'Gangrene', 'MP:0003384', 'abnormal ventral body wall morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350935, 'HP:0100758', 'Gangrene', 'MP:0000003', 'abnormal adipose tissue morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350936, 'HP:0100758', 'Gangrene', 'MP:0002132', 'abnormal respiratory system morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350937, 'HP:0100758', 'Gangrene', 'MP:0030675', 'abnormal acetylcholine level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350938, 'HP:0100758', 'Gangrene', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.4444444444444444, 1.6758249395539064, 0.8630243821852199, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350939, 'HP:0100758', 'Gangrene', 'MP:0002006', 'neoplasm', 0.42857142857142855, 1.5524157786304194, 0.8156721449114622, 'UPHENO:0001003', 'phenotype by ontology source'),
(350940, 'HP:0100758', 'Gangrene', 'MP:0005332', 'abnormal amino acid level', 0.4444444444444444, 1.6758249395539064, 0.8630243821852199, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350941, 'HP:0100758', 'Gangrene', 'MP:0005384', 'cellular phenotype', 0.42857142857142855, 1.5524157786304194, 0.8156721449114622, 'UPHENO:0001003', 'phenotype by ontology source'),
(350942, 'HP:0100758', 'Gangrene', 'MP:0020297', 'abnormal UDP-N-acetylglucosamine-1-phosphotransferase level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350943, 'HP:0100758', 'Gangrene', 'MP:0002873', 'normal phenotype', 0.42857142857142855, 1.5524157786304194, 0.8156721449114622, 'UPHENO:0001003', 'phenotype by ontology source'),
(350944, 'HP:0100758', 'Gangrene', 'MP:0000428', 'abnormal craniofacial morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350945, 'HP:0100758', 'Gangrene', 'MP:0003860', 'abnormal carbon dioxide level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350946, 'HP:0100758', 'Gangrene', 'MP:0030621', 'abnormal cysteine level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350947, 'HP:0100758', 'Gangrene', 'MP:0005394', 'taste/olfaction phenotype', 0.42857142857142855, 1.5524157786304194, 0.8156721449114622, 'UPHENO:0001003', 'phenotype by ontology source'),
(350948, 'HP:0100758', 'Gangrene', 'MP:0005387', 'immune system phenotype', 0.42857142857142855, 1.5524157786304194, 0.8156721449114622, 'UPHENO:0001003', 'phenotype by ontology source'),
(350949, 'HP:0100758', 'Gangrene', 'MP:0013113', 'greasy tail', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350950, 'HP:0100758', 'Gangrene', 'MP:0014136', 'abnormal extraembryonic endoderm morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350951, 'HP:0100758', 'Gangrene', 'MP:0000685', 'abnormal immune system morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350952, 'HP:0100758', 'Gangrene', 'MP:0001186', 'pigmentation phenotype', 0.42857142857142855, 1.5524157786304194, 0.8156721449114622, 'UPHENO:0001003', 'phenotype by ontology source'),
(350953, 'HP:0100758', 'Gangrene', 'MP:0004134', 'abnormal chest morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350954, 'HP:0100758', 'Gangrene', 'MP:0002108', 'abnormal muscle morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350955, 'HP:0100758', 'Gangrene', 'MP:0005499', 'abnormal olfactory system morphology', 0.4444444444444444, 1.6758249395539064, 0.8630243821852199, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350956, 'HP:0100758', 'Gangrene', 'MP:0005382', 'craniofacial phenotype', 0.42857142857142855, 1.5524157786304194, 0.8156721449114622, 'UPHENO:0001003', 'phenotype by ontology source'),
(350957, 'HP:0100758', 'Gangrene', 'MP:0000516', 'abnormal renal/urinary system morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350958, 'HP:0100758', 'Gangrene', 'MP:0011475', 'abnormal glycosaminoglycan level', 0.4444444444444444, 1.6758249395539064, 0.8630243821852199, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350959, 'HP:0100758', 'Gangrene', 'MP:0020294', 'abnormal guanylate cyclase activating protein-2 level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350960, 'HP:0100758', 'Gangrene', 'MP:0000001', 'mammalian phenotype', 0.46153846153846156, 1.5524157786304194, 0.8464629880491625, 'UPHENO:0001003', 'phenotype by ontology source'),
(350961, 'HP:0100758', 'Gangrene', 'MP:0003279', 'aneurysm', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350962, 'HP:0100758', 'Gangrene', 'MP:0005377', 'hearing/vestibular/ear phenotype', 0.42857142857142855, 1.5524157786304194, 0.8156721449114622, 'UPHENO:0001003', 'phenotype by ontology source'),
(350963, 'HP:0100758', 'Gangrene', 'MP:0020982', 'abnormal skin adnexa development', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350964, 'HP:0100758', 'Gangrene', 'MP:0021145', 'abnormal amino acid derivative level', 0.4444444444444444, 1.6758249395539064, 0.8630243821852199, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350965, 'HP:0100758', 'Gangrene', 'MP:0000192', 'abnormal mineral level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350966, 'HP:0100758', 'Gangrene', 'MP:0003631', 'nervous system phenotype', 0.42857142857142855, 1.5524157786304194, 0.8156721449114622, 'UPHENO:0001003', 'phenotype by ontology source'),
(350967, 'HP:0100758', 'Gangrene', 'MP:0021149', 'abnormal amyloid beta protein level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350968, 'HP:0100758', 'Gangrene', 'MP:0021122', 'abnormal trimethylamine N-oxide level', 0.4444444444444444, 1.6758249395539064, 0.8630243821852199, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350969, 'HP:0100758', 'Gangrene', 'MP:0020291', 'abnormal dystrophin level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350970, 'HP:0100758', 'Gangrene', 'MP:0003385', 'abnormal body wall morphology', 0.4444444444444444, 1.6758249395539064, 0.8630243821852199, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350971, 'HP:0100758', 'Gangrene', 'MP:0005380', 'embryo phenotype', 0.42857142857142855, 1.5524157786304194, 0.8156721449114622, 'UPHENO:0001003', 'phenotype by ontology source'),
(350972, 'HP:0100758', 'Gangrene', 'MP:0011989', 'abnormal porphyrin level', 0.4444444444444444, 1.6758249395539064, 0.8630243821852199, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350973, 'HP:0100758', 'Gangrene', 'MP:0005379', 'endocrine/exocrine gland phenotype', 0.42857142857142855, 1.5524157786304194, 0.8156721449114622, 'UPHENO:0001003', 'phenotype by ontology source'),
(350974, 'HP:0100758', 'Gangrene', 'MP:0001547', 'abnormal lipid level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350975, 'HP:0100758', 'Gangrene', 'MP:0000462', 'abnormal digestive system morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350976, 'HP:0100758', 'Gangrene', 'MP:0005389', 'reproductive system phenotype', 0.42857142857142855, 1.5524157786304194, 0.8156721449114622, 'UPHENO:0001003', 'phenotype by ontology source'),
(350977, 'HP:0100758', 'Gangrene', 'MP:0020252', 'abnormal collagen level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350978, 'HP:0100758', 'Gangrene', 'MP:0010678', 'abnormal skin adnexa morphology', 0.4444444444444444, 1.6758249395539064, 0.8630243821852199, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350979, 'HP:0100758', 'Gangrene', 'MP:0005375', 'adipose tissue phenotype', 0.42857142857142855, 1.5524157786304194, 0.8156721449114622, 'UPHENO:0001003', 'phenotype by ontology source'),
(350980, 'HP:0100758', 'Gangrene', 'MP:0005370', 'liver/biliary system phenotype', 0.42857142857142855, 1.5524157786304194, 0.8156721449114622, 'UPHENO:0001003', 'phenotype by ontology source'),
(350981, 'HP:0100758', 'Gangrene', 'MP:0008835', 'abnormal intercellular signaling peptide or protein level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350982, 'HP:0100758', 'Gangrene', 'MP:0031272', 'abnormal susceptibility to induced aneurysm formation', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350983, 'HP:0100758', 'Gangrene', 'MP:0003632', 'abnormal nervous system morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350984, 'HP:0100758', 'Gangrene', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.4444444444444444, 1.6758249395539064, 0.8630243821852199, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350985, 'HP:0100758', 'Gangrene', 'MP:0005369', 'muscle phenotype', 0.42857142857142855, 1.5524157786304194, 0.8156721449114622, 'UPHENO:0001003', 'phenotype by ontology source'),
(350986, 'HP:0100758', 'Gangrene', 'MP:0002109', 'abnormal limb morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350987, 'HP:0100758', 'Gangrene', 'MP:0001574', 'abnormal oxygen level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350988, 'HP:0100758', 'Gangrene', 'MP:0008923', 'thoracoschisis', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350989, 'HP:0100758', 'Gangrene', 'MP:0030741', 'abnormal aspartic acid level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350990, 'HP:0100758', 'Gangrene', 'MP:0020973', 'abnormal gland development', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350991, 'HP:0100758', 'Gangrene', 'MP:0013332', 'peliosis', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350992, 'HP:0100758', 'Gangrene', 'MP:0002396', 'abnormal hematopoietic system morphology/development', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350993, 'HP:0100758', 'Gangrene', 'MP:0011479', 'abnormal catecholamine level', 0.4444444444444444, 1.6758249395539064, 0.8630243821852199, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350994, 'HP:0100758', 'Gangrene', 'MP:0002925', 'abnormal cardiovascular development', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350995, 'HP:0100758', 'Gangrene', 'MP:0030752', 'abnormal choline level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350996, 'HP:0100758', 'Gangrene', 'MP:0005320', 'abnormal biopterin level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350997, 'HP:0100758', 'Gangrene', 'MP:0005508', 'abnormal skeleton morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350998, 'HP:0100758', 'Gangrene', 'MP:0002111', 'abnormal tail morphology', 0.4444444444444444, 1.6758249395539064, 0.8630243821852199, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(350999, 'HP:0100758', 'Gangrene', 'MP:0005322', 'abnormal serotonin level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(351000, 'HP:0100758', 'Gangrene', 'MP:0005390', 'skeleton phenotype', 0.42857142857142855, 1.5524157786304194, 0.8156721449114622, 'UPHENO:0001003', 'phenotype by ontology source'),
(351001, 'HP:0100758', 'Gangrene', 'MP:0008469', 'abnormal protein level', 0.4444444444444444, 1.6758249395539064, 0.8630243821852199, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(351002, 'HP:0000484', 'Hyperopic astigmatism', 'MP:0006151', 'astigmatism', 0.5540540540540541, 14.607147267911275, 2.8448460699923364, 'UPHENO:0031199', 'abnormal cornea, asymmetrically curved'),
(351003, 'HP:0033692', 'Declarative memory loss', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351004, 'HP:0033692', 'Declarative memory loss', 'MP:0006058', 'decreased cerebral infarct size', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351005, 'HP:0033692', 'Declarative memory loss', 'MP:0013806', 'encephalopathy', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351006, 'HP:0033692', 'Declarative memory loss', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(351007, 'HP:0033692', 'Declarative memory loss', 'MP:0003471', 'abnormal summary potential threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351008, 'HP:0033692', 'Declarative memory loss', 'MP:0004494', 'abnormal synaptic glutamate release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351009, 'HP:0033692', 'Declarative memory loss', 'MP:0005403', 'abnormal nerve conduction', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351010, 'HP:0033692', 'Declarative memory loss', 'MP:0003463', 'abnormal single cell response', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351011, 'HP:0033692', 'Declarative memory loss', 'MP:0004513', 'avnosmia', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351012, 'HP:0033692', 'Declarative memory loss', 'MP:0003465', 'increased single cell response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351013, 'HP:0033692', 'Declarative memory loss', 'MP:0005645', 'abnormal hypothalamus physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351014, 'HP:0033692', 'Declarative memory loss', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(351015, 'HP:0033692', 'Declarative memory loss', 'MP:0003635', 'abnormal synaptic transmission', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351016, 'HP:0033692', 'Declarative memory loss', 'MP:0003467', 'abnormal single cell response intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351017, 'HP:0033692', 'Declarative memory loss', 'MP:0002915', 'abnormal synaptic depression', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351018, 'HP:0033692', 'Declarative memory loss', 'MP:0010149', 'abnormal synaptic dopamine release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351019, 'HP:0033692', 'Declarative memory loss', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351020, 'HP:0033692', 'Declarative memory loss', 'MP:0002910', 'abnormal excitatory postsynaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351021, 'HP:0033692', 'Declarative memory loss', 'MP:0002886', 'abnormal glutamate-mediated receptor currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351022, 'HP:0033692', 'Declarative memory loss', 'MP:0002133', 'abnormal respiratory system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(351023, 'HP:0033692', 'Declarative memory loss', 'MP:0014255', 'increased paired-pulse inhibition', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351024, 'HP:0033692', 'Declarative memory loss', 'MP:0003997', 'tonic-clonic seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351025, 'HP:0033692', 'Declarative memory loss', 'MP:0001752', 'abnormal hypothalamus secretion', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351026, 'HP:0033692', 'Declarative memory loss', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(351027, 'HP:0033692', 'Declarative memory loss', 'MP:0004753', 'abnormal miniature excitatory postsynaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351028, 'HP:0033692', 'Declarative memory loss', 'MP:0021016', 'decreased tau protein phosphorylation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351029, 'HP:0033692', 'Declarative memory loss', 'MP:0003412', 'abnormal afterhyperpolarization', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351030, 'HP:0033692', 'Declarative memory loss', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351031, 'HP:0033692', 'Declarative memory loss', 'MP:0030990', 'nerve inflammation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351032, 'HP:0033692', 'Declarative memory loss', 'MP:0021010', 'impaired synaptic physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351033, 'HP:0033692', 'Declarative memory loss', 'MP:0003880', 'abnormal central pattern generator function', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351034, 'HP:0033692', 'Declarative memory loss', 'MP:0003482', 'increased nerve fiber response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351035, 'HP:0033692', 'Declarative memory loss', 'MP:0001912', 'increased cerebrospinal fluid production', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351036, 'HP:0033692', 'Declarative memory loss', 'MP:0003444', 'abnormal neurotransmitter uptake', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351037, 'HP:0033692', 'Declarative memory loss', 'MP:0002204', 'abnormal synaptic neurotransmitter level', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351038, 'HP:0033692', 'Declarative memory loss', 'MP:0000947', 'convulsive seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351039, 'HP:0033692', 'Declarative memory loss', 'MP:0001790', 'abnormal immune system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(351040, 'HP:0033692', 'Declarative memory loss', 'MP:0002914', 'abnormal endplate potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351041, 'HP:0033692', 'Declarative memory loss', 'MP:0002206', 'abnormal CNS synaptic transmission', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351042, 'HP:0033692', 'Declarative memory loss', 'MP:0005446', 'abnormal synaptic epinephrine release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351043, 'HP:0033692', 'Declarative memory loss', 'MP:0003990', 'decreased neurotransmitter release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351044, 'HP:0033692', 'Declarative memory loss', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351045, 'HP:0033692', 'Declarative memory loss', 'MP:0012011', 'febrile seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351046, 'HP:0033692', 'Declarative memory loss', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(351047, 'HP:0033692', 'Declarative memory loss', 'MP:0002207', 'abnormal long-term potentiation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351048, 'HP:0033692', 'Declarative memory loss', 'MP:0000427', 'abnormal hair cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(351049, 'HP:0033692', 'Declarative memory loss', 'MP:0003475', 'increased summary potential intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351050, 'HP:0033692', 'Declarative memory loss', 'MP:0004836', 'abnormal synaptic acetylcholine release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351051, 'HP:0033692', 'Declarative memory loss', 'MP:0004859', 'abnormal synaptic plasticity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351052, 'HP:0033692', 'Declarative memory loss', 'MP:0001533', 'abnormal skeleton physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(351053, 'HP:0033692', 'Declarative memory loss', 'MP:0003474', 'abnormal summary potential intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351054, 'HP:0033692', 'Declarative memory loss', 'MP:0014120', 'focal seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351055, 'HP:0033692', 'Declarative memory loss', 'MP:0003483', 'decreased nerve fiber response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351056, 'HP:0033692', 'Declarative memory loss', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351057, 'HP:0033692', 'Declarative memory loss', 'MP:0003469', 'decreased single cell response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351058, 'HP:0033692', 'Declarative memory loss', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(351059, 'HP:0033692', 'Declarative memory loss', 'MP:0002193', 'minimal clonic seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351060, 'HP:0033692', 'Declarative memory loss', 'MP:0002911', 'abnormal inhibitory postsynaptic potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351061, 'HP:0033692', 'Declarative memory loss', 'MP:0006060', 'increased cerebral infarct size', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351062, 'HP:0033692', 'Declarative memory loss', 'MP:0003470', 'abnormal summary potential', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351063, 'HP:0033692', 'Declarative memory loss', 'MP:0004835', 'abnormal miniature endplate potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351064, 'HP:0033692', 'Declarative memory loss', 'MP:0012348', 'decreased susceptibility to induction of seizure by inducing agent', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351065, 'HP:0033692', 'Declarative memory loss', 'MP:0001650', 'abnormal seizure response to electrical stimulation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351066, 'HP:0033692', 'Declarative memory loss', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351067, 'HP:0033692', 'Declarative memory loss', 'MP:0003472', 'increased summary potential threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351068, 'HP:0033692', 'Declarative memory loss', 'MP:0014256', 'decreased paired-pulse inhibition', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351069, 'HP:0033692', 'Declarative memory loss', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(351070, 'HP:0033692', 'Declarative memory loss', 'MP:0001663', 'abnormal digestive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(351071, 'HP:0033692', 'Declarative memory loss', 'MP:0003220', 'decreased spike-wave discharge type II', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351072, 'HP:0033692', 'Declarative memory loss', 'MP:0009244', 'abnormal acid-activated cation-mediated receptor currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351073, 'HP:0033692', 'Declarative memory loss', 'MP:0009358', 'environmentally induced seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351074, 'HP:0033692', 'Declarative memory loss', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(351075, 'HP:0033692', 'Declarative memory loss', 'MP:0021001', 'impaired neuron physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351076, 'HP:0033692', 'Declarative memory loss', 'MP:0000951', 'sporadic seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351077, 'HP:0033692', 'Declarative memory loss', 'MP:0020424', 'increased kindling response', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351078, 'HP:0033692', 'Declarative memory loss', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351079, 'HP:0033692', 'Declarative memory loss', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351080, 'HP:0033692', 'Declarative memory loss', 'MP:0004811', 'abnormal neuron physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351081, 'HP:0033692', 'Declarative memory loss', 'MP:0002918', 'abnormal paired-pulse facilitation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351082, 'HP:0033692', 'Declarative memory loss', 'MP:0009435', 'abnormal miniature inhibitory postsynaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351083, 'HP:0033692', 'Declarative memory loss', 'MP:0000948', 'nonconvulsive seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351084, 'HP:0033692', 'Declarative memory loss', 'MP:0002164', 'abnormal gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(351085, 'HP:0033692', 'Declarative memory loss', 'MP:0002920', 'decreased paired-pulse facilitation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351086, 'HP:0033692', 'Declarative memory loss', 'MP:0006277', 'abnormal parasympathetic nervous system physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351087, 'HP:0033692', 'Declarative memory loss', 'MP:0003088', 'abnormal prepulse inhibition', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351088, 'HP:0033692', 'Declarative memory loss', 'MP:0002912', 'abnormal excitatory postsynaptic potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351089, 'HP:0033692', 'Declarative memory loss', 'MP:0002945', 'abnormal inhibitory postsynaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351090, 'HP:0033692', 'Declarative memory loss', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(351091, 'HP:0033692', 'Declarative memory loss', 'MP:0002578', 'impaired ability to fire action potentials', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351092, 'HP:0033692', 'Declarative memory loss', 'MP:0014254', 'increased paired-pulse ratio', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351093, 'HP:0033692', 'Declarative memory loss', 'MP:0006080', 'brain ischemia', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351094, 'HP:0033692', 'Declarative memory loss', 'MP:0004183', 'abnormal sympathetic nervous system physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351095, 'HP:0033692', 'Declarative memory loss', 'MP:0006059', 'decreased susceptibility to ischemic brain injury', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351096, 'HP:0033692', 'Declarative memory loss', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351097, 'HP:0033692', 'Declarative memory loss', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(351098, 'HP:0033692', 'Declarative memory loss', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351099, 'HP:0033692', 'Declarative memory loss', 'MP:0003486', 'abnormal channel response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351100, 'HP:0033692', 'Declarative memory loss', 'MP:0004768', 'abnormal axonal transport', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351101, 'HP:0033692', 'Declarative memory loss', 'MP:0002919', 'enhanced paired-pulse facilitation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351102, 'HP:0033692', 'Declarative memory loss', 'MP:0003889', 'enhanced sensorimotor gating', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351103, 'HP:0033692', 'Declarative memory loss', 'MP:0003485', 'abnormal channel response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351104, 'HP:0033692', 'Declarative memory loss', 'MP:0003217', 'increased spike-wave discharge type I', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351105, 'HP:0033692', 'Declarative memory loss', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351106, 'HP:0033692', 'Declarative memory loss', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351107, 'HP:0033692', 'Declarative memory loss', 'MP:0001500', 'decreased kindling response', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351108, 'HP:0033692', 'Declarative memory loss', 'MP:0005402', 'abnormal action potential', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351109, 'HP:0033692', 'Declarative memory loss', 'MP:0001496', 'audiogenic seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351110, 'HP:0033692', 'Declarative memory loss', 'MP:0005621', 'abnormal cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(351111, 'HP:0033692', 'Declarative memory loss', 'MP:0000920', 'abnormal myelination', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351112, 'HP:0033692', 'Declarative memory loss', 'MP:0014253', 'decreased paired-pulse ratio', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351113, 'HP:0033692', 'Declarative memory loss', 'MP:0000950', 'abnormal seizure response to pharmacological agent', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351114, 'HP:0033692', 'Declarative memory loss', 'MP:0001499', 'abnormal kindling response', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351115, 'HP:0033692', 'Declarative memory loss', 'MP:0014252', 'abnormal paired-pulse ratio', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351116, 'HP:0033692', 'Declarative memory loss', 'MP:0005445', 'abnormal neurotransmitter secretion', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351117, 'HP:0033692', 'Declarative memory loss', 'MP:0001985', 'abnormal gustatory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(351118, 'HP:0033692', 'Declarative memory loss', 'MP:0020371', 'abnormal glymphatic system physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351119, 'HP:0033692', 'Declarative memory loss', 'MP:0006082', 'CNS inflammation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351120, 'HP:0033692', 'Declarative memory loss', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351121, 'HP:0033692', 'Declarative memory loss', 'MP:0008814', 'decreased nerve conduction velocity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351122, 'HP:0033692', 'Declarative memory loss', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351123, 'HP:0033692', 'Declarative memory loss', 'MP:0003481', 'decreased nerve fiber response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351124, 'HP:0033692', 'Declarative memory loss', 'MP:0003218', 'decreased spike-wave discharge type I', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351125, 'HP:0033692', 'Declarative memory loss', 'MP:0001919', 'abnormal reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(351126, 'HP:0033692', 'Declarative memory loss', 'MP:0002634', 'abnormal sensorimotor gating', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351127, 'HP:0033692', 'Declarative memory loss', 'MP:0001984', 'abnormal olfaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(351128, 'HP:0033692', 'Declarative memory loss', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351129, 'HP:0033692', 'Declarative memory loss', 'MP:0004994', 'abnormal brain wave pattern', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351130, 'HP:0033692', 'Declarative memory loss', 'MP:0010050', 'hypermyelination', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351131, 'HP:0033692', 'Declarative memory loss', 'MP:0004807', 'abnormal paired-pulse inhibition', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351132, 'HP:0033692', 'Declarative memory loss', 'MP:0013438', 'dysmyelination', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351133, 'HP:0033692', 'Declarative memory loss', 'MP:0021009', 'abnormal synaptic physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351134, 'HP:0033692', 'Declarative memory loss', 'MP:0004008', 'abnormal GABA-mediated receptor currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351135, 'HP:0033692', 'Declarative memory loss', 'MP:0021015', 'increased tau protein phosphorylation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351136, 'HP:0033692', 'Declarative memory loss', 'MP:0002635', 'reduced sensorimotor gating', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351137, 'HP:0033692', 'Declarative memory loss', 'MP:0003216', 'absence seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351138, 'HP:0033692', 'Declarative memory loss', 'MP:0005447', 'abnormal synaptic norepinephrine release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351139, 'HP:0033692', 'Declarative memory loss', 'MP:0008921', 'increased neurotransmitter release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351140, 'HP:0033692', 'Declarative memory loss', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351141, 'HP:0033692', 'Declarative memory loss', 'MP:0009475', 'abnormal nicotine-mediated receptor currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351142, 'HP:0033692', 'Declarative memory loss', 'MP:0002064', 'seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351143, 'HP:0033692', 'Declarative memory loss', 'MP:0011994', 'increased nerve conduction velocity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351144, 'HP:0033692', 'Declarative memory loss', 'MP:0003473', 'decreased summary potential threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351145, 'HP:0033692', 'Declarative memory loss', 'MP:0001986', 'abnormal taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(351146, 'HP:0033692', 'Declarative memory loss', 'MP:0005666', 'abnormal adipose tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(351147, 'HP:0033692', 'Declarative memory loss', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(351148, 'HP:0033692', 'Declarative memory loss', 'MP:0002921', 'abnormal post-tetanic potentiation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351149, 'HP:0033692', 'Declarative memory loss', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351150, 'HP:0033692', 'Declarative memory loss', 'MP:0003480', 'increased nerve fiber response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351151, 'HP:0033692', 'Declarative memory loss', 'MP:0003466', 'decreased single cell response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351152, 'HP:0033692', 'Declarative memory loss', 'MP:0011399', 'increased endoneurial fluid pressure', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351153, 'HP:0033692', 'Declarative memory loss', 'MP:0010680', 'abnormal skin adnexa physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(351154, 'HP:0033692', 'Declarative memory loss', 'MP:0001900', 'impaired synaptic plasticity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351155, 'HP:0033692', 'Declarative memory loss', 'MP:0003633', 'abnormal nervous system physiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351156, 'HP:0033692', 'Declarative memory loss', 'MP:0003484', 'abnormal channel response', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351157, 'HP:0033692', 'Declarative memory loss', 'MP:0012349', 'increased susceptibility to induction of seizure by inducing agent', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351158, 'HP:0033692', 'Declarative memory loss', 'MP:0003219', 'increased spike-wave discharge type II', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351159, 'HP:0033692', 'Declarative memory loss', 'MP:0012685', 'abnormal primitive streak elongation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(351160, 'HP:0033692', 'Declarative memory loss', 'MP:0003464', 'abnormal single cell response threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351161, 'HP:0033692', 'Declarative memory loss', 'MP:0011987', 'abnormal GABAergic neuron physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351162, 'HP:0033692', 'Declarative memory loss', 'MP:0031092', 'dysgeusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(351163, 'HP:0033692', 'Declarative memory loss', 'MP:0002195', 'psychomotor seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351164, 'HP:0033692', 'Declarative memory loss', 'MP:0003076', 'increased susceptibility to ischemic brain injury', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351165, 'HP:0033692', 'Declarative memory loss', 'MP:0012006', 'abnormal hippocampus physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351166, 'HP:0033692', 'Declarative memory loss', 'MP:0002194', 'maximal tonic hindlimb extension seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351167, 'HP:0033692', 'Declarative memory loss', 'MP:0003468', 'increased single cell response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351168, 'HP:0033692', 'Declarative memory loss', 'MP:0003476', 'decreased summary potential intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351169, 'HP:0033692', 'Declarative memory loss', 'MP:0001983', 'abnormal olfactory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(351170, 'HP:0033692', 'Declarative memory loss', 'MP:0002106', 'abnormal muscle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(351171, 'HP:0033692', 'Declarative memory loss', 'MP:0003996', 'clonic seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351172, 'HP:0033692', 'Declarative memory loss', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351173, 'HP:0033692', 'Declarative memory loss', 'MP:0004558', 'delayed allantois development', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(351174, 'HP:0033692', 'Declarative memory loss', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351175, 'HP:0033692', 'Declarative memory loss', 'MP:0011397', 'endoneurial edema', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351176, 'HP:0033692', 'Declarative memory loss', 'MP:0000921', 'demyelination', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351177, 'HP:0033692', 'Declarative memory loss', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351178, 'HP:0033692', 'Declarative memory loss', 'MP:0004770', 'abnormal synaptic vesicle recycling', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351179, 'HP:0033692', 'Declarative memory loss', 'MP:0003477', 'abnormal nerve fiber response', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351180, 'HP:0033692', 'Declarative memory loss', 'MP:0002913', 'abnormal PNS synaptic transmission', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351181, 'HP:0033692', 'Declarative memory loss', 'MP:0008840', 'abnormal spike wave discharge', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351182, 'HP:0033692', 'Declarative memory loss', 'MP:0002826', 'tonic seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351183, 'HP:0033692', 'Declarative memory loss', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351184, 'HP:0012584', 'Bilateral renal hypoplasia', 'MP:0011423', 'kidney cortex atrophy', 0.4423076923076923, 13.285219173023913, 2.424078099860257, 'UPHENO:0069110', 'decreased size of the kidney'),
(351185, 'HP:0012584', 'Bilateral renal hypoplasia', 'MP:0003446', 'renal hypoplasia', 0.6, 15.607147267911275, 3.060112475179101, 'UPHENO:0081210', 'kidney hypoplasia'),
(351186, 'HP:0012584', 'Bilateral renal hypoplasia', 'MP:0003626', 'kidney medulla hypoplasia', 0.5106382978723404, 8.202005804774931, 2.0465234626774564, 'UPHENO:0081790', 'anatomical entity hypoplasia in independent continuant'),
(351187, 'HP:0012584', 'Bilateral renal hypoplasia', 'MP:0003918', 'decreased kidney weight', 0.4423076923076923, 13.285219173023913, 2.424078099860257, 'UPHENO:0069110', 'decreased size of the kidney'),
(351188, 'HP:0012584', 'Bilateral renal hypoplasia', 'MP:0000734', 'muscle hypoplasia', 0.41304347826086957, 8.202005804774931, 1.8405936559491016, 'UPHENO:0081790', 'anatomical entity hypoplasia in independent continuant'),
(351189, 'HP:0012584', 'Bilateral renal hypoplasia', 'MP:0002707', 'abnormal kidney weight', 0.43478260869565216, 12.548253578857707, 2.3357573558891573, 'UPHENO:0075182', 'abnormal size of kidney'),
(351190, 'HP:0012584', 'Bilateral renal hypoplasia', 'MP:0011360', 'kidney cortex hypoplasia', 0.5106382978723404, 8.202005804774931, 2.0465234626774564, 'UPHENO:0081790', 'anatomical entity hypoplasia in independent continuant'),
(351191, 'HP:0012584', 'Bilateral renal hypoplasia', 'MP:0004970', 'kidney atrophy', 0.48936170212765956, 13.285219173023913, 2.5497602765064014, 'UPHENO:0069110', 'decreased size of the kidney'),
(351192, 'HP:0012584', 'Bilateral renal hypoplasia', 'MP:0011346', 'renal tubule atrophy', 0.41818181818181815, 13.285219173023913, 2.3570399039301586, 'UPHENO:0069110', 'decreased size of the kidney'),
(351193, 'HP:0012584', 'Bilateral renal hypoplasia', 'MP:0002706', 'abnormal kidney size', 0.46511627906976744, 12.548253578857707, 2.415863616478006, 'UPHENO:0075182', 'abnormal size of kidney'),
(351194, 'HP:0012584', 'Bilateral renal hypoplasia', 'MP:0011412', 'gonadal ridge hypoplasia', 0.4166666666666667, 8.202005804774931, 1.848648808902389, 'UPHENO:0081790', 'anatomical entity hypoplasia in independent continuant'),
(351195, 'HP:0012584', 'Bilateral renal hypoplasia', 'MP:0011298', 'ureter hypoplasia', 0.4782608695652174, 8.202005804774931, 1.9805803261596384, 'UPHENO:0081790', 'anatomical entity hypoplasia in independent continuant'),
(351196, 'HP:0012584', 'Bilateral renal hypoplasia', 'MP:0002989', 'small kidney', 0.5227272727272727, 13.285219173023913, 2.635250725433704, 'UPHENO:0069110', 'decreased size of the kidney'),
(351197, 'HP:0012584', 'Bilateral renal hypoplasia', 'MP:0011565', 'kidney papillary hypoplasia', 0.43636363636363634, 8.202005804774931, 1.8918396016700894, 'UPHENO:0081790', 'anatomical entity hypoplasia in independent continuant'),
(351198, 'HP:0012584', 'Bilateral renal hypoplasia', 'MP:0011844', 'kidney collecting duct atrophy', 0.40384615384615385, 7.667568053596582, 1.759692549225182, 'UPHENO:0076779', 'abnormal kidney morphology'),
(351199, 'HP:0012584', 'Bilateral renal hypoplasia', 'MP:0011422', 'kidney medulla atrophy', 0.4423076923076923, 13.285219173023913, 2.424078099860257, 'UPHENO:0069110', 'decreased size of the kidney'),
(351200, 'HP:0012584', 'Bilateral renal hypoplasia', 'MP:0003617', 'urinary bladder hypoplasia', 0.42857142857142855, 8.202005804774931, 1.87487208761119, 'UPHENO:0081790', 'anatomical entity hypoplasia in independent continuant'),
(351201, 'HP:0012584', 'Bilateral renal hypoplasia', 'MP:0000071', 'axial skeleton hypoplasia', 0.40425531914893614, 8.202005804774931, 1.8209075963021069, 'UPHENO:0081790', 'anatomical entity hypoplasia in independent continuant'),
(351202, 'HP:0012584', 'Bilateral renal hypoplasia', 'MP:0002955', 'increased compensatory renal growth', 0.45454545454545453, 12.548253578857707, 2.3882528397875933, 'UPHENO:0075182', 'abnormal size of kidney'),
(351203, 'HP:0012584', 'Bilateral renal hypoplasia', 'MP:0011365', 'small metanephros', 0.46, 13.285219173023913, 2.472084306732074, 'UPHENO:0069110', 'decreased size of the kidney'),
(351204, 'HP:0012584', 'Bilateral renal hypoplasia', 'MP:0002956', 'decreased compensatory renal growth', 0.45454545454545453, 12.548253578857707, 2.3882528397875933, 'UPHENO:0075182', 'abnormal size of kidney'),
(351205, 'HP:0012584', 'Bilateral renal hypoplasia', 'MP:0000526', 'small inner medullary pyramid', 0.42, 7.667568053596582, 1.7945413292846069, 'UPHENO:0076779', 'abnormal kidney morphology'),
(351206, 'HP:0031585', 'Tessier number 13 facial cleft', 'MP:0009578', 'otocephaly', 0.425531914893617, 6.5236679405794336, 1.6661419239923307, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(351207, 'HP:0031585', 'Tessier number 13 facial cleft', 'MP:0011495', 'abnormal head shape', 0.43478260869565216, 6.5236679405794336, 1.684154792609432, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(351208, 'HP:0031585', 'Tessier number 13 facial cleft', 'MP:0000448', 'pointed snout', 0.4230769230769231, 6.5236679405794336, 1.6613287933085112, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(351209, 'HP:0031585', 'Tessier number 13 facial cleft', 'MP:0030045', 'abnormal forehead shape', 0.44, 6.5236679405794336, 1.6942295871147306, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(351210, 'HP:0031585', 'Tessier number 13 facial cleft', 'MP:0008799', 'oblique facial cleft', 0.5957446808510638, 13.437222266468964, 2.8293380304697355, 'UPHENO:0041242', 'split face'),
(351211, 'HP:0031585', 'Tessier number 13 facial cleft', 'MP:0030071', 'abnormal face shape', 0.5555555555555556, 12.700256672302759, 2.6562564167036493, 'UPHENO:0005983', 'abnormal shape of face'),
(351212, 'HP:0031585', 'Tessier number 13 facial cleft', 'MP:0012175', 'flat face', 0.4716981132075472, 12.700256672302759, 2.447588018759851, 'UPHENO:0005983', 'abnormal shape of face'),
(351213, 'HP:0031585', 'Tessier number 13 facial cleft', 'MP:0030072', 'round face', 0.4716981132075472, 12.700256672302759, 2.447588018759851, 'UPHENO:0005983', 'abnormal shape of face'),
(351214, 'HP:0031585', 'Tessier number 13 facial cleft', 'MP:0030099', 'facial asymmetry', 0.46296296296296297, 12.700256672302759, 2.4248192632440517, 'UPHENO:0005983', 'abnormal shape of face'),
(351215, 'HP:0031585', 'Tessier number 13 facial cleft', 'MP:0030063', 'abnormal face size', 0.425531914893617, 11.592196926445306, 2.2210019711684574, 'UPHENO:0020809', 'abnormal face morphology'),
(351216, 'HP:0031585', 'Tessier number 13 facial cleft', 'MP:0030049', 'prominent forehead', 0.4074074074074074, 6.5236679405794336, 1.6302731803161972, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(351217, 'HP:0031585', 'Tessier number 13 facial cleft', 'MP:0008797', 'facial cleft', 0.6086956521739131, 13.437222266468964, 2.859926357599816, 'UPHENO:0041242', 'split face'),
(351218, 'HP:0031585', 'Tessier number 13 facial cleft', 'MP:0008798', 'lateral facial cleft', 0.5957446808510638, 13.437222266468964, 2.8293380304697355, 'UPHENO:0041242', 'split face'),
(351219, 'HP:0031585', 'Tessier number 13 facial cleft', 'MP:0030073', 'square face', 0.5, 12.700256672302759, 2.519946097866258, 'UPHENO:0005983', 'abnormal shape of face'),
(351220, 'HP:0031585', 'Tessier number 13 facial cleft', 'MP:0006290', 'proboscis', 0.425531914893617, 6.5236679405794336, 1.6661419239923307, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(351221, 'HP:0031585', 'Tessier number 13 facial cleft', 'MP:0031501', 'abnormal mouth shape', 0.4074074074074074, 6.5236679405794336, 1.6302731803161972, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(351222, 'HP:0031585', 'Tessier number 13 facial cleft', 'MP:0000108', 'midline facial cleft', 0.56, 13.437222266468964, 2.743144996026025, 'UPHENO:0041242', 'split face'),
(351223, 'HP:0031585', 'Tessier number 13 facial cleft', 'MP:0012546', 'triangular face', 0.49019607843137253, 12.700256672302759, 2.495118437235933, 'UPHENO:0005983', 'abnormal shape of face'),
(351224, 'HP:0031585', 'Tessier number 13 facial cleft', 'MP:0030074', 'coarse facial features', 0.5434782608695652, 12.700256672302759, 2.6272254202599736, 'UPHENO:0005983', 'abnormal shape of face'),
(351225, 'HP:0031585', 'Tessier number 13 facial cleft', 'MP:0030048', 'sloping forehead', 0.41509433962264153, 6.5236679405794336, 1.6455812455519228, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(351226, 'HP:0004722', 'Thickened glomerular basement membrane', 'MP:0011294', 'renal glomerulus hypertrophy', 0.40350877192982454, 9.804092483287297, 1.9889789636438293, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(351227, 'HP:0004722', 'Thickened glomerular basement membrane', 'MP:0011349', 'abnormal renal glomerulus basement membrane thickness', 0.41818181818181815, 9.804092483287297, 2.0248193055884713, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(351228, 'HP:0004722', 'Thickened glomerular basement membrane', 'MP:0005325', 'abnormal renal glomerulus morphology', 0.40816326530612246, 9.804092483287297, 2.0004175567470295, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(351229, 'HP:0004722', 'Thickened glomerular basement membrane', 'MP:0011377', 'renal glomerulus fibrosis', 0.42592592592592593, 9.804092483287297, 2.0434816291827906, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(351230, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0001105', 'abnormal PNS glial cell morphology', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351231, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0003864', 'abnormal midbrain development', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351232, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0001891', 'hydrocephaly', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351233, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0008493', 'alpha-synuclein inclusion body', 0.5217391304347826, 5.028460092616607, 1.6197359032100866, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351234, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0003384', 'abnormal ventral body wall morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351235, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0010310', 'increased Schwannoma incidence', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351236, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0003385', 'abnormal body wall morphology', 0.45454545454545453, 2.6504988612427964, 1.0976211594424627, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351237, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0004277', 'abnormal lateral ganglionic eminence morphology', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351238, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0031274', 'increased susceptibility to induced aneurysm formation', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351239, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0002924', 'delayed CNS synapse formation', 0.5, 5.028460092616607, 1.5856323805688075, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351240, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0020829', 'abnormal forebrain tissue architecture', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351241, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0009027', 'abnormal subarachnoid space morphology', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351242, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0020973', 'abnormal gland development', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351243, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0000685', 'abnormal immune system morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351244, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0011199', 'abnormal amniotic cavity morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351245, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0004166', 'abnormal limbic system morphology', 0.42857142857142855, 5.028460092616607, 1.4680103287808015, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351246, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0009023', 'abnormal spinal cord meninges morphology', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351247, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0005499', 'abnormal olfactory system morphology', 0.45454545454545453, 2.6504988612427964, 1.0976211594424627, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351248, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0001929', 'abnormal gametogenesis', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351249, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0012545', 'syringomyelia', 0.48, 5.028460092616607, 1.5535961008112666, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351250, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0002210', 'abnormal sex determination', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351251, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0013119', 'abdomen swellings', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351252, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0013177', 'abnormal tail tip morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351253, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0001033', 'abnormal parasympathetic system morphology', 0.42857142857142855, 5.028460092616607, 1.4680103287808015, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351254, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0002654', 'spongiform encephalopathy', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351255, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0000516', 'abnormal renal/urinary system morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351256, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0031377', 'ambiguous external genitalia', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351257, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0005500', 'abnormal gustatory system morphology', 0.45454545454545453, 2.6504988612427964, 1.0976211594424627, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351258, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.45454545454545453, 2.6504988612427964, 1.0976211594424627, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351259, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0004203', 'abnormal cranial flexure morphology', 0.42857142857142855, 5.028460092616607, 1.4680103287808015, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351260, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0013438', 'dysmyelination', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351261, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0000847', 'abnormal metencephalon morphology', 0.42857142857142855, 5.028460092616607, 1.4680103287808015, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351262, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0000266', 'abnormal heart morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351263, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0005457', 'abnormal percent body fat/body weight', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351264, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0020981', 'abnormal immune system development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351265, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0002653', 'abnormal ependyma morphology', 0.5217391304347826, 5.028460092616607, 1.6197359032100866, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351266, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0000961', 'abnormal dorsal root ganglion morphology', 0.40625, 9.516152735690683, 1.966198629049044, 'UPHENO:0088183', 'abnormal ganglion morphology'),
(351267, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0009686', 'abnormal spinal cord medial motor column morphology', 0.42857142857142855, 5.028460092616607, 1.4680103287808015, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351268, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0002152', 'abnormal brain morphology', 0.5, 5.028460092616607, 1.5856323805688075, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351269, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0008027', 'abnormal spinal cord white matter morphology', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351270, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0014137', 'abnormal preimplantation embryo morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351271, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0010050', 'hypermyelination', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351272, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0002752', 'abnormal somatic nervous system morphology', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351273, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0014065', 'Lewy bodies', 0.5217391304347826, 5.028460092616607, 1.6197359032100866, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351274, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0003632', 'abnormal nervous system morphology', 0.5714285714285714, 5.028460092616607, 1.6951123169894935, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351275, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0020370', 'abnormal glymphatic system morphology', 0.5217391304347826, 5.028460092616607, 1.6197359032100866, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351276, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0008026', 'abnormal brain white matter morphology', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351277, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0011167', 'abnormal adipose tissue development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351278, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0002229', 'neurodegeneration', 0.42857142857142855, 5.028460092616607, 1.4680103287808015, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351279, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0013562', 'abnormal circumventricular organ morphology', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351280, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0010311', 'increased meningioma incidence', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351281, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0000952', 'abnormal CNS glial cell morphology', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351282, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0013934', 'supratentorial ventricles enlargement', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351283, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0005277', 'abnormal brainstem morphology', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351284, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0003890', 'abnormal embryonic-extraembryonic boundary morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351285, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0005112', 'abnormal spinal cord ventral horn morphology', 0.42857142857142855, 5.028460092616607, 1.4680103287808015, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351286, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0000921', 'demyelination', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351287, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0000462', 'abnormal digestive system morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351288, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0013558', 'abnormal exocrine gland morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351289, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0011174', 'lipodystrophy', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351290, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0000914', 'exencephaly', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351291, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0003115', 'abnormal respiratory system development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351292, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0000960', 'abnormal sensory ganglion morphology', 0.43333333333333335, 9.516152735690683, 2.0306812121714137, 'UPHENO:0088183', 'abnormal ganglion morphology'),
(351293, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0020452', 'abnormal axon radial sorting', 0.5217391304347826, 5.028460092616607, 1.6197359032100866, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351294, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0001718', 'abnormal visceral yolk sac morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351295, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0012132', 'abnormal midbrain-hindbrain boundary morphology', 0.42857142857142855, 5.028460092616607, 1.4680103287808015, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351296, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.45454545454545453, 2.6504988612427964, 1.0976211594424627, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351297, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0000003', 'abnormal adipose tissue morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351298, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0000954', 'decreased oligodendrocyte progenitor number', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351299, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0014063', 'Lafora bodies', 0.5217391304347826, 5.028460092616607, 1.6197359032100866, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351300, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0001726', 'abnormal allantois morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351301, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0000913', 'abnormal brain development', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351302, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0002108', 'abnormal muscle morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351303, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0003232', 'abnormal forebrain development', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351304, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0010126', 'abnormal distal visceral endoderm morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351305, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0005157', 'holoprosencephaly', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351306, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0000841', 'abnormal hindbrain morphology', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351307, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0004134', 'abnormal chest morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351308, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0004274', 'abnormal embryonic/fetal subventricular zone morphology', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351309, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0014067', 'Hirano bodies', 0.5217391304347826, 5.028460092616607, 1.6197359032100866, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351310, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0009688', 'abnormal spinal cord central canal morphology', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351311, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0010478', 'intracranial aneurysm', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351312, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0013123', 'head/neck swellings', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351313, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0013564', 'abnormal sensory circumventricular organ morphology', 0.42857142857142855, 5.028460092616607, 1.4680103287808015, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351314, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0004276', 'abnormal medial ganglionic eminence morphology', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351315, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0005360', 'urolithiasis', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351316, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0000783', 'abnormal forebrain morphology', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351317, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0030222', 'hyperostosis', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351318, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0006281', 'abnormal tail development', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351319, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0003795', 'abnormal bone structure', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351320, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0000752', 'dystrophic muscle', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351321, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0008311', 'abnormal parasympathetic preganglionic fiber morphology', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351322, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0010678', 'abnormal skin adnexa morphology', 0.45454545454545453, 2.6504988612427964, 1.0976211594424627, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351323, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0013120', 'urogenital swellings', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351324, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0008025', 'brain vacuoles', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351325, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0002109', 'abnormal limb morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351326, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0001052', 'abnormal innervation pattern to muscle', 0.5, 5.028460092616607, 1.5856323805688075, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351327, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0000920', 'abnormal myelination', 0.42857142857142855, 5.028460092616607, 1.4680103287808015, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351328, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0014134', 'abnormal embryo morphology', 0.45454545454545453, 2.6504988612427964, 1.0976211594424627, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351329, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0004278', 'abnormal caudal ganglionic eminence morphology', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351330, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0001051', 'abnormal somatic motor system morphology', 0.42857142857142855, 5.028460092616607, 1.4680103287808015, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351331, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0003300', 'gastrointestinal ulcer', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351332, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0009679', 'abnormal spinal cord ventral column morphology', 0.42857142857142855, 5.028460092616607, 1.4680103287808015, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351333, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0011203', 'abnormal parietal yolk sac morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351334, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0002836', 'abnormal chorion morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351335, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0002163', 'abnormal gland morphology', 0.45454545454545453, 2.6504988612427964, 1.0976211594424627, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351336, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0009804', 'abnormal interventricular foramen morphology', 0.42857142857142855, 5.028460092616607, 1.4680103287808015, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351337, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0008312', 'abnormal sympathetic postganglionic fiber morphology', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351338, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0031310', 'abnormal cyst', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351339, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0008533', 'abnormal anterior visceral endoderm morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351340, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0003279', 'aneurysm', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351341, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0002751', 'abnormal autonomic nervous system morphology', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351342, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0031273', 'decreased susceptibility to induced aneurysm formation', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351343, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0009694', 'abnormal spinal cord commissure morphology', 0.42857142857142855, 5.028460092616607, 1.4680103287808015, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351344, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0003861', 'abnormal nervous system development', 0.5454545454545454, 5.028460092616607, 1.656139008101226, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351345, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0003935', 'abnormal craniofacial development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351346, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0030572', 'abnormal pilosebaceous unit morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351347, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0013125', 'thorax swellings', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351348, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0013122', 'tail swellings', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351349, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0012711', 'diplomyelia', 0.48, 5.028460092616607, 1.5535961008112666, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351350, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0002085', 'abnormal embryonic tissue morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351351, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0003119', 'abnormal digestive system development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351352, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0013126', 'teat swellings', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351353, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0001077', 'abnormal spinal nerve morphology', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351354, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0005623', 'abnormal meninges morphology', 0.5, 5.028460092616607, 1.5856323805688075, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351355, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0002184', 'abnormal innervation', 0.5217391304347826, 5.028460092616607, 1.6197359032100866, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351356, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0002132', 'abnormal respiratory system morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351357, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0014278', 'semilobar holoprosencephaly', 0.42857142857142855, 5.028460092616607, 1.4680103287808015, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351358, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0002151', 'abnormal neural tube morphology', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351359, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0014066', 'Rosenthal fibers', 0.5217391304347826, 5.028460092616607, 1.6197359032100866, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351360, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0014136', 'abnormal extraembryonic endoderm morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351361, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0009682', 'abnormal anterior corticospinal tract morphology', 0.42857142857142855, 5.028460092616607, 1.4680103287808015, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351362, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0013935', 'basal brain tissue herniation', 0.48, 5.028460092616607, 1.5535961008112666, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351363, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0012500', 'abnormal angioblastic cord morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351364, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0005508', 'abnormal skeleton morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351365, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0010281', 'increased nervous system tumor incidence', 0.42857142857142855, 5.028460092616607, 1.4680103287808015, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351366, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0013915', 'abnormal brachial plexus formation', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351367, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0008317', 'abnormal paravertebral ganglion morphology', 0.40625, 9.516152735690683, 1.966198629049044, 'UPHENO:0088183', 'abnormal ganglion morphology'),
(351368, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0010744', 'abnormal cervical flexure morphology', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351369, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0002183', 'gliosis', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351370, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0002396', 'abnormal hematopoietic system morphology/development', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351371, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0010233', 'hairless tail', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351372, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0006279', 'abnormal limb development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351373, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0010278', 'increased glioma incidence', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351374, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0005029', 'abnormal amnion morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351375, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0000778', 'abnormal nervous system tract morphology', 0.5, 5.028460092616607, 1.5856323805688075, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351376, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0013332', 'peliosis', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351377, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0014064', 'argyrophilic inclusion bodies', 0.5217391304347826, 5.028460092616607, 1.6197359032100866, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351378, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0014061', 'ethmocephaly', 0.42857142857142855, 5.028460092616607, 1.4680103287808015, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351379, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0009685', 'abnormal spinal cord motor column morphology', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351380, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0014149', 'abnormal lacrimal gland innervation pattern', 0.5, 5.028460092616607, 1.5856323805688075, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351381, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0009678', 'abnormal spinal cord lateral column morphology', 0.42857142857142855, 5.028460092616607, 1.4680103287808015, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351382, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0003329', 'amyloid beta deposits', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351383, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0003942', 'abnormal urinary system development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351384, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0005657', 'abnormal neural plate morphology', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351385, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0002113', 'abnormal skeleton development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351386, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0031277', 'pectus carinatum', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351387, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0014062', 'nervous system inclusion bodies', 0.5454545454545454, 5.028460092616607, 1.656139008101226, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351388, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0002778', 'meroanencephaly', 0.5, 5.028460092616607, 1.5856323805688075, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351389, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0009022', 'abnormal brain meninges morphology', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351390, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0009677', 'abnormal spinal cord dorsal column morphology', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351391, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0014276', 'lobar holoprosencephaly', 0.42857142857142855, 5.028460092616607, 1.4680103287808015, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351392, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0008923', 'thoracoschisis', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351393, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0001007', 'abnormal sympathetic system morphology', 0.42857142857142855, 5.028460092616607, 1.4680103287808015, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351394, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0001044', 'abnormal enteric nervous system morphology', 0.42857142857142855, 5.028460092616607, 1.4680103287808015, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351395, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0013121', 'testicular swellings', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351396, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0003894', 'abnormal Purkinje cell innervation', 0.5, 5.028460092616607, 1.5856323805688075, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351397, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0000897', 'abnormal midbrain morphology', 0.42857142857142855, 5.028460092616607, 1.4680103287808015, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351398, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0003634', 'abnormal glial cell morphology', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351399, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0013124', 'mouth swellings', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351400, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0002878', 'abnormal corticospinal tract morphology', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351401, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0002160', 'abnormal reproductive system morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351402, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0004250', 'tau protein deposits', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351403, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0006007', 'abnormal basal ganglion morphology', 0.42857142857142855, 5.028460092616607, 1.4680103287808015, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351404, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0008310', 'abnormal sympathetic preganglionic fiber morphology', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351405, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0013133', 'pale limbs', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351406, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0020982', 'abnormal skin adnexa development', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351407, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0021002', 'brain lesion', 0.48, 5.028460092616607, 1.5535961008112666, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351408, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0013113', 'greasy tail', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351409, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0000822', 'abnormal brain ventricle morphology', 0.42857142857142855, 5.028460092616607, 1.4680103287808015, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351410, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0003936', 'abnormal reproductive system development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351411, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0002925', 'abnormal cardiovascular development', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351412, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0010892', 'increased oligodendrocyte progenitor number', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351413, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0009037', 'abnormal subarachnoid space development', 0.42857142857142855, 5.028460092616607, 1.4680103287808015, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351414, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0000733', 'abnormal muscle development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351415, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0004996', 'abnormal CNS synapse formation', 0.5217391304347826, 5.028460092616607, 1.6197359032100866, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351416, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0010736', 'abnormal extraembryonic ectoderm morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351417, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.45454545454545453, 2.6504988612427964, 1.0976211594424627, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351418, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0002111', 'abnormal tail morphology', 0.45454545454545453, 2.6504988612427964, 1.0976211594424627, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351419, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0031272', 'abnormal susceptibility to induced aneurysm formation', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351420, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0008503', 'abnormal spinal cord grey matter morphology', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351421, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0009277', 'increased brain tumor incidence', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351422, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0001890', 'anencephaly', 0.5217391304347826, 5.028460092616607, 1.6197359032100866, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351423, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0010362', 'increased ganglioneuroma incidence', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351424, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0008857', 'myelencephalic blebs', 0.42857142857142855, 5.028460092616607, 1.4680103287808015, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351425, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0010361', 'increased gangliosarcoma incidence', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351426, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0001889', 'delayed brain development', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351427, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0009032', 'abnormal subarachnoid cistern morphology', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351428, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0000955', 'abnormal spinal cord morphology', 0.5, 5.028460092616607, 1.5856323805688075, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351429, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0012423', 'decreased nervous system tumor incidence', 0.42857142857142855, 5.028460092616607, 1.4680103287808015, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351430, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0006108', 'abnormal hindbrain development', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351431, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0008313', 'abnormal parasympathetic postganglionic fiber morphology', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351432, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0011200', 'abnormal extraembryonic coelom morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351433, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0000959', 'abnormal somatic sensory system morphology', 0.42857142857142855, 5.028460092616607, 1.4680103287808015, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351434, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0014277', 'alobar holoprosencephaly', 0.42857142857142855, 5.028460092616607, 1.4680103287808015, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351435, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0031099', 'abnormal sputum morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351436, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0013118', 'swellings', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351437, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0004997', 'increased CNS synapse formation', 0.5, 5.028460092616607, 1.5856323805688075, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351438, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0013283', 'failure of ventral body wall closure', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351439, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0003214', 'neurofibrillary tangles', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351440, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0020826', 'increased oculomotor nerve neuroma incidence', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351441, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0012514', 'pectus excavatum', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351442, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0012260', 'encephalomeningocele', 0.5454545454545454, 5.028460092616607, 1.656139008101226, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351443, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0001034', 'abnormal parasympathetic ganglion morphology', 0.41935483870967744, 9.516152735690683, 1.9976598047746323, 'UPHENO:0088183', 'abnormal ganglion morphology'),
(351444, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0001008', 'abnormal sympathetic ganglion morphology', 0.41935483870967744, 9.516152735690683, 1.9976598047746323, 'UPHENO:0088183', 'abnormal ganglion morphology'),
(351445, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0002200', 'abnormal brain ventricular system morphology', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351446, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0006282', 'abnormal spinal cord dorsal horn morphology', 0.42857142857142855, 5.028460092616607, 1.4680103287808015, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351447, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0000830', 'abnormal diencephalon morphology', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351448, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0010352', 'gastrointestinal tract polyps', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351449, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0000787', 'abnormal telencephalon morphology', 0.42857142857142855, 5.028460092616607, 1.4680103287808015, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351450, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0000428', 'abnormal craniofacial morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(351451, 'HP:0410014', 'Abnormal ganglion morphology', 'MP:0004998', 'decreased CNS synapse formation', 0.5, 5.028460092616607, 1.5856323805688075, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(351452, 'HP:0010508', 'Metatarsus valgus', 'MP:0004641', 'elongated metatarsal bones', 0.45714285714285713, 11.548253578857707, 2.2976513303913713, 'UPHENO:0020817', 'abnormal metatarsal bone morphology'),
(351453, 'HP:0010508', 'Metatarsus valgus', 'MP:0030825', 'decreased femur size', 0.4264705882352941, 7.694257931681313, 1.8114565151165531, 'UPHENO:0079871', 'abnormal anatomical entity morphology in the skeleton of pelvic complex'),
(351454, 'HP:0010508', 'Metatarsus valgus', 'MP:0004642', 'fused metatarsal bones', 0.45714285714285713, 11.548253578857707, 2.2976513303913713, 'UPHENO:0020817', 'abnormal metatarsal bone morphology'),
(351455, 'HP:0010508', 'Metatarsus valgus', 'MP:0008158', 'increased diameter of femur', 0.4142857142857143, 7.694257931681313, 1.7853910336744485, 'UPHENO:0079871', 'abnormal anatomical entity morphology in the skeleton of pelvic complex'),
(351456, 'HP:0010508', 'Metatarsus valgus', 'MP:0004635', 'short metatarsal bones', 0.45714285714285713, 11.548253578857707, 2.2976513303913713, 'UPHENO:0020817', 'abnormal metatarsal bone morphology'),
(351457, 'HP:0010508', 'Metatarsus valgus', 'MP:0030823', 'increased femur size', 0.4264705882352941, 7.694257931681313, 1.8114565151165531, 'UPHENO:0079871', 'abnormal anatomical entity morphology in the skeleton of pelvic complex'),
(351458, 'HP:0010508', 'Metatarsus valgus', 'MP:0030827', 'femur fracture', 0.43283582089552236, 7.694257931681313, 1.8249247787350484, 'UPHENO:0079871', 'abnormal anatomical entity morphology in the skeleton of pelvic complex'),
(351459, 'HP:0010508', 'Metatarsus valgus', 'MP:0008152', 'decreased diameter of femur', 0.4142857142857143, 7.694257931681313, 1.7853910336744485, 'UPHENO:0079871', 'abnormal anatomical entity morphology in the skeleton of pelvic complex'),
(351460, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0030990', 'nerve inflammation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351461, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0002206', 'abnormal CNS synaptic transmission', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351462, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351463, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0006080', 'brain ischemia', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351464, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0011987', 'abnormal GABAergic neuron physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351465, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0003471', 'abnormal summary potential threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351466, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0014256', 'decreased paired-pulse inhibition', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351467, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0002920', 'decreased paired-pulse facilitation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351468, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0010680', 'abnormal skin adnexa physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(351469, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0004811', 'abnormal neuron physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351470, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(351471, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0003470', 'abnormal summary potential', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351472, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0012011', 'febrile seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351473, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0003474', 'abnormal summary potential intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351474, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(351475, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351476, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0021016', 'decreased tau protein phosphorylation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351477, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0002826', 'tonic seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351478, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0006058', 'decreased cerebral infarct size', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351479, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0002195', 'psychomotor seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351480, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0001650', 'abnormal seizure response to electrical stimulation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351481, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0021010', 'impaired synaptic physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351482, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0002910', 'abnormal excitatory postsynaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351483, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0004770', 'abnormal synaptic vesicle recycling', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351484, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0004183', 'abnormal sympathetic nervous system physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351485, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0004836', 'abnormal synaptic acetylcholine release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351486, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0005645', 'abnormal hypothalamus physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351487, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0004835', 'abnormal miniature endplate potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351488, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351489, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(351490, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0006059', 'decreased susceptibility to ischemic brain injury', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351491, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0003484', 'abnormal channel response', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351492, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0003216', 'absence seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351493, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0002634', 'abnormal sensorimotor gating', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351494, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0002635', 'reduced sensorimotor gating', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351495, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0002578', 'impaired ability to fire action potentials', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351496, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0003444', 'abnormal neurotransmitter uptake', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351497, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0005447', 'abnormal synaptic norepinephrine release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351498, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0014252', 'abnormal paired-pulse ratio', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351499, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0004008', 'abnormal GABA-mediated receptor currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351500, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(351501, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0014255', 'increased paired-pulse inhibition', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351502, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0003220', 'decreased spike-wave discharge type II', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351503, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0002194', 'maximal tonic hindlimb extension seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351504, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0004513', 'avnosmia', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351505, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0003088', 'abnormal prepulse inhibition', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351506, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0001912', 'increased cerebrospinal fluid production', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351507, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0003468', 'increased single cell response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351508, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0003486', 'abnormal channel response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351509, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351510, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0003476', 'decreased summary potential intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351511, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0001499', 'abnormal kindling response', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351512, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(351513, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0001496', 'audiogenic seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351514, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0004494', 'abnormal synaptic glutamate release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351515, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0012348', 'decreased susceptibility to induction of seizure by inducing agent', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351516, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0001500', 'decreased kindling response', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351517, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0011994', 'increased nerve conduction velocity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351518, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0014253', 'decreased paired-pulse ratio', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351519, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351520, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0004753', 'abnormal miniature excitatory postsynaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351521, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0003076', 'increased susceptibility to ischemic brain injury', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351522, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0001663', 'abnormal digestive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(351523, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(351524, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0014254', 'increased paired-pulse ratio', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351525, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0005621', 'abnormal cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(351526, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0003217', 'increased spike-wave discharge type I', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351527, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0020371', 'abnormal glymphatic system physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351528, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0008814', 'decreased nerve conduction velocity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351529, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0003480', 'increased nerve fiber response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351530, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0002919', 'enhanced paired-pulse facilitation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351531, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0006060', 'increased cerebral infarct size', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351532, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0002912', 'abnormal excitatory postsynaptic potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351533, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0002164', 'abnormal gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(351534, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0005666', 'abnormal adipose tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(351535, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0012006', 'abnormal hippocampus physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351536, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351537, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0012685', 'abnormal primitive streak elongation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(351538, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0014120', 'focal seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351539, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0013806', 'encephalopathy', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351540, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0003996', 'clonic seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351541, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0021001', 'impaired neuron physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351542, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0000920', 'abnormal myelination', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351543, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0009435', 'abnormal miniature inhibitory postsynaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351544, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(351545, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0002945', 'abnormal inhibitory postsynaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351546, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0002913', 'abnormal PNS synaptic transmission', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351547, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0001790', 'abnormal immune system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(351548, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0020424', 'increased kindling response', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351549, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0004768', 'abnormal axonal transport', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351550, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0003218', 'decreased spike-wave discharge type I', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351551, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0002193', 'minimal clonic seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351552, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0005446', 'abnormal synaptic epinephrine release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351553, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0001986', 'abnormal taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(351554, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0003880', 'abnormal central pattern generator function', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351555, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0003464', 'abnormal single cell response threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351556, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0003633', 'abnormal nervous system physiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351557, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351558, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0001983', 'abnormal olfactory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(351559, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0004807', 'abnormal paired-pulse inhibition', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351560, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0000947', 'convulsive seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351561, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0000427', 'abnormal hair cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(351562, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0003466', 'decreased single cell response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351563, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0003477', 'abnormal nerve fiber response', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351564, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0001752', 'abnormal hypothalamus secretion', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351565, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0003635', 'abnormal synaptic transmission', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351566, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351567, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0002921', 'abnormal post-tetanic potentiation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351568, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0000948', 'nonconvulsive seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351569, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0010149', 'abnormal synaptic dopamine release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351570, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0002064', 'seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351571, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351572, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0000951', 'sporadic seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351573, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0002911', 'abnormal inhibitory postsynaptic potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351574, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351575, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0005402', 'abnormal action potential', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351576, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351577, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0031092', 'dysgeusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(351578, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0001900', 'impaired synaptic plasticity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351579, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0001919', 'abnormal reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(351580, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0013438', 'dysmyelination', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351581, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351582, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0003469', 'decreased single cell response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351583, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0004558', 'delayed allantois development', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(351584, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0012349', 'increased susceptibility to induction of seizure by inducing agent', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351585, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0011397', 'endoneurial edema', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351586, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351587, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0009244', 'abnormal acid-activated cation-mediated receptor currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351588, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0005445', 'abnormal neurotransmitter secretion', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351589, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0003463', 'abnormal single cell response', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351590, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351591, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351592, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0009358', 'environmentally induced seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351593, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0003473', 'decreased summary potential threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351594, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0002204', 'abnormal synaptic neurotransmitter level', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351595, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0002207', 'abnormal long-term potentiation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351596, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0021009', 'abnormal synaptic physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351597, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0008921', 'increased neurotransmitter release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351598, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0003481', 'decreased nerve fiber response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351599, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0002914', 'abnormal endplate potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351600, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0002106', 'abnormal muscle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(351601, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0010050', 'hypermyelination', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351602, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351603, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0003482', 'increased nerve fiber response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351604, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0011399', 'increased endoneurial fluid pressure', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351605, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0021015', 'increased tau protein phosphorylation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351606, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0003990', 'decreased neurotransmitter release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351607, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0005403', 'abnormal nerve conduction', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351608, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0003465', 'increased single cell response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351609, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0002886', 'abnormal glutamate-mediated receptor currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351610, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0002133', 'abnormal respiratory system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(351611, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0003467', 'abnormal single cell response intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351612, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(351613, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0000950', 'abnormal seizure response to pharmacological agent', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351614, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0003889', 'enhanced sensorimotor gating', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351615, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0002918', 'abnormal paired-pulse facilitation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351616, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0004859', 'abnormal synaptic plasticity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351617, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351618, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0003483', 'decreased nerve fiber response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351619, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0001533', 'abnormal skeleton physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(351620, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0004994', 'abnormal brain wave pattern', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351621, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0002915', 'abnormal synaptic depression', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351622, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351623, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0006082', 'CNS inflammation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351624, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0001984', 'abnormal olfaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(351625, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(351626, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0003997', 'tonic-clonic seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351627, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0000921', 'demyelination', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351628, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351629, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0009475', 'abnormal nicotine-mediated receptor currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351630, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0008840', 'abnormal spike wave discharge', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351631, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(351632, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0003472', 'increased summary potential threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351633, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0006277', 'abnormal parasympathetic nervous system physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351634, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0003485', 'abnormal channel response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351635, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0003412', 'abnormal afterhyperpolarization', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351636, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0001985', 'abnormal gustatory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(351637, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0003475', 'increased summary potential intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351638, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351639, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351640, 'HP:0032901', 'Focal pedal automatism seizure', 'MP:0003219', 'increased spike-wave discharge type II', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(351641, 'HP:0025179', 'Ground-glass opacification', 'MP:0002330', 'abnormal bronchial provocation', 0.42424242424242425, 8.526773851447254, 1.9019514214892284, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(351642, 'HP:0025179', 'Ground-glass opacification', 'MP:0002338', 'abnormal pulmonary ventilation', 0.42424242424242425, 8.526773851447254, 1.9019514214892284, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(351643, 'HP:0025179', 'Ground-glass opacification', 'MP:0006050', 'pulmonary fibrosis', 0.4166666666666667, 7.528551664415159, 1.7711286025694604, 'UPHENO:0087433', 'abnormal respiratory system morphology'),
(351644, 'HP:0025179', 'Ground-glass opacification', 'MP:0005586', 'decreased tidal volume', 0.43902439024390244, 8.526773851447254, 1.9348027524477225, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(351645, 'HP:0025179', 'Ground-glass opacification', 'MP:0031102', 'rhinorrhea', 0.45161290322580644, 8.526773851447254, 1.962345814121962, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(351646, 'HP:0025179', 'Ground-glass opacification', 'MP:0001954', 'respiratory distress', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(351647, 'HP:0025179', 'Ground-glass opacification', 'MP:0031105', 'rhonchi', 0.42424242424242425, 8.526773851447254, 1.9019514214892284, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(351648, 'HP:0025179', 'Ground-glass opacification', 'MP:0001947', 'abnormal mucociliary clearance', 0.45161290322580644, 8.526773851447254, 1.962345814121962, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(351649, 'HP:0025179', 'Ground-glass opacification', 'MP:0031098', 'abnormal sputum production', 0.45161290322580644, 8.526773851447254, 1.962345814121962, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(351650, 'HP:0025179', 'Ground-glass opacification', 'MP:0011044', 'increased lung elastance', 0.4375, 8.526773851447254, 1.9314407989913058, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(351651, 'HP:0025179', 'Ground-glass opacification', 'MP:0011046', 'abnormal lung tissue damping', 0.45161290322580644, 8.526773851447254, 1.962345814121962, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(351652, 'HP:0025179', 'Ground-glass opacification', 'MP:0001942', 'abnormal lung volume', 0.46153846153846156, 8.526773851447254, 1.983792853420777, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(351653, 'HP:0025179', 'Ground-glass opacification', 'MP:0002334', 'abnormal airway responsiveness', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(351654, 'HP:0025179', 'Ground-glass opacification', 'MP:0001943', 'abnormal respiration', 0.45161290322580644, 8.526773851447254, 1.962345814121962, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(351655, 'HP:0025179', 'Ground-glass opacification', 'MP:0001951', 'abnormal breathing pattern', 0.42424242424242425, 8.526773851447254, 1.9019514214892284, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(351656, 'HP:0025179', 'Ground-glass opacification', 'MP:0014027', 'abnormal respiratory epithelial chloride transmembrane transport', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(351657, 'HP:0025179', 'Ground-glass opacification', 'MP:0005575', 'increased pulmonary ventilation', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(351658, 'HP:0025179', 'Ground-glass opacification', 'MP:0002328', 'abnormal airway resistance', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(351659, 'HP:0025179', 'Ground-glass opacification', 'MP:0031089', 'sneezing', 0.45161290322580644, 8.526773851447254, 1.962345814121962, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(351660, 'HP:0025179', 'Ground-glass opacification', 'MP:0031088', 'coughing', 0.45161290322580644, 8.526773851447254, 1.962345814121962, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(351661, 'HP:0025179', 'Ground-glass opacification', 'MP:0002297', 'abnormal forced expiratory flow rates', 0.42424242424242425, 8.526773851447254, 1.9019514214892284, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(351662, 'HP:0025179', 'Ground-glass opacification', 'MP:0011047', 'increased lung tissue damping', 0.4375, 8.526773851447254, 1.9314407989913058, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(351663, 'HP:0025179', 'Ground-glass opacification', 'MP:0005585', 'increased tidal volume', 0.43902439024390244, 8.526773851447254, 1.9348027524477225, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(351664, 'HP:0025179', 'Ground-glass opacification', 'MP:0002304', 'abnormal total lung capacity', 0.43902439024390244, 8.526773851447254, 1.9348027524477225, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(351665, 'HP:0025179', 'Ground-glass opacification', 'MP:0001950', 'abnormal respiratory sounds', 0.4375, 8.526773851447254, 1.9314407989913058, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(351666, 'HP:0025179', 'Ground-glass opacification', 'MP:0013752', 'stridor', 0.42424242424242425, 8.526773851447254, 1.9019514214892284, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(351667, 'HP:0025179', 'Ground-glass opacification', 'MP:0010937', 'increased total lung capacity', 0.42857142857142855, 8.526773851447254, 1.911630626093925, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(351668, 'HP:0025179', 'Ground-glass opacification', 'MP:0005576', 'decreased pulmonary ventilation', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
